_MEMBER_data_imp_1 - 1.8-2.2,_MEMBER_data_imp_1 - 4.5-5.5,_MEMBER_data_imp_1 - 9.0-11.0,_LogP_data_imp_1 - 1.8-2.2,_LogP_data_imp_1 - 4.5-5.5,_LogP_data_imp_1 - 9.0-11.0,GO,Description,_PATTERN_,_RANK_,GiniIndex
1,1,1,-11,-5.9,-3.8,GO:0010720,positive regulation of cell development,M111,3,0
1,1,1,-4.5,-3.6,-3.1,GO:0048736,appendage development,M111,3,0
1,1,1,-5,-3,-2.9,WP395,IL 4 signaling pathway,M111,3,0
1,1,1,-4.8,-2.6,-3.7,GO:0046634,regulation of alpha-beta T cell activation,M111,3,0
1,1,1,-4.6,-4,-3.2,GO:0035108,limb morphogenesis,M111,3,0
1,1,1,-6.8,-8.4,-4.3,M167,PID AP1 PATHWAY,M111,3,0
1,1,1,-2.1,-2.1,-2.5,M285,PID HNF3A PATHWAY,M111,3,0
1,1,1,-13,-7.1,-4.5,GO:0042110,T cell activation,M111,3,0
1,1,1,-7,-5,-4.1,WP3527,Pre implantation embryo,M111,3,0
1,1,1,-3.1,-4.1,-5.5,GO:1904888,cranial skeletal system development,M111,3,0
1,1,1,-5.3,-3.5,-3.4,GO:0042113,B cell activation,M111,3,0
1,1,1,-3.2,-3.8,-4.3,GO:0048706,embryonic skeletal system development,M111,3,0
1,1,1,-3.6,-2.6,-3.7,WP363,Wnt signaling pathway,M111,3,0
1,1,1,-8.9,-5.8,-2.8,GO:0003002,regionalization,M111,3,0
1,1,1,-9.5,-8.8,-5.9,GO:0045165,cell fate commitment,M111,3,0
1,1,1,-3.9,-2.2,-2.3,GO:0021885,forebrain cell migration,M111,3,0
1,1,1,-6.4,-2.8,-2.6,hsa05321,Inflammatory bowel disease,M111,3,0
1,1,1,-4.3,-4.9,-3.4,R-HSA-166520,Signaling by NTRKs,M111,3,0
1,1,1,-18,-10,-14,GO:0030097,hemopoiesis,M111,3,0
1,1,1,-5.2,-3.6,-3.3,GO:0002366,leukocyte activation involved in immune response,M111,3,0
1,1,1,-5.6,-4.2,-3.7,GO:0045619,regulation of lymphocyte differentiation,M111,3,0
1,1,1,-5.4,-4.4,-2.2,GO:0050679,positive regulation of epithelial cell proliferation,M111,3,0
1,1,1,-6.5,-2.4,-2.7,hsa05417,Lipid and atherosclerosis,M111,3,0
1,1,1,-4.7,-2.4,-6.5,WP69,T cell receptor signaling pathway,M111,3,0
1,1,1,-3.3,-3.4,-2,WP673,ErbB signaling pathway,M111,3,0
1,1,1,-7.1,-4.3,-4.2,hsa05202,Transcriptional misregulation in cancer,M111,3,0
1,1,1,-5.3,-4.1,-6,GO:0045639,positive regulation of myeloid cell differentiation,M111,3,0
1,1,1,-5,-6.2,-4.6,M60,PID NFAT TFPATHWAY,M111,3,0
1,1,1,-2,-2.8,-2.7,GO:0045586,regulation of gamma-delta T cell differentiation,M111,3,0
1,1,1,-4.1,-3.8,-4.8,WP2840,Hair follicle development cytodifferentiation part 3 of 3,M111,3,0
1,1,1,-15,-9.9,-10,GO:0002521,leukocyte differentiation,M111,3,0
1,1,1,-8.5,-6.2,-7.8,WP4149,White fat cell differentiation,M111,3,0
1,1,1,-10,-4.1,-2.9,hsa04659,Th17 cell differentiation,M111,3,0
1,1,1,-3.1,-3.1,-2.7,WP428,Wnt signaling,M111,3,0
1,1,1,-14,-5,-4.5,GO:0001819,positive regulation of cytokine production,M111,3,0
1,1,1,-5.7,-3.3,-2.6,GO:0032675,regulation of interleukin-6 production,M111,3,0
1,1,1,-9.1,-2.7,-3.9,hsa05161,Hepatitis B,M111,3,0
1,1,1,-5,-3,-3.7,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,M111,3,0
1,1,1,-4,-3.1,-3.3,WP4540,Hippo signaling regulation pathways,M111,3,0
1,1,1,-4.9,-3.3,-2.2,GO:0009952,anterior/posterior pattern specification,M111,3,0
1,1,1,-5.3,-5.3,-3.2,R-HSA-9031628,NGF-stimulated transcription,M111,3,0
1,1,1,-3.5,-2.6,-2.8,GO:0001910,regulation of leukocyte mediated cytotoxicity,M111,3,0
1,1,1,-6.4,-2.6,-2.8,GO:0051101,regulation of DNA binding,M111,3,0
1,1,1,-2.8,-3,-3.3,GO:0050871,positive regulation of B cell activation,M111,3,0
1,1,1,-9.3,-5.9,-2.1,GO:0048469,cell maturation,M111,3,0
1,1,1,-7.2,-4.2,-3.4,GO:0001763,morphogenesis of a branching structure,M111,3,0
1,1,1,-8.3,-3.7,-3.7,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,M111,3,0
1,1,1,-9.5,-4.2,-2.8,GO:0002697,regulation of immune effector process,M111,3,0
1,1,1,-9.2,-4.6,-2.7,GO:0061351,neural precursor cell proliferation,M111,3,0
1,1,1,-11,-5.8,-4.9,GO:0030217,T cell differentiation,M111,3,0
1,1,1,-13,-8.1,-7.7,GO:1903131,mononuclear cell differentiation,M111,3,0
1,1,1,-2.5,-3.9,-2.4,R-HSA-9700206,Signaling by ALK in cancer,M111,3,0
1,1,1,-4.5,-5.5,-3.7,GO:0071772,response to BMP,M111,3,0
1,1,1,-2,-2.8,-2.3,M164,PID ERBB1 DOWNSTREAM PATHWAY,M111,3,0
1,1,1,-3.2,-6.4,-2,GO:0048844,artery morphogenesis,M111,3,0
1,1,1,-4.6,-4,-3.2,GO:0035107,appendage morphogenesis,M111,3,0
1,1,1,-3,-3,-2.1,GO:0043584,nose development,M111,3,0
1,1,1,-7,-2.1,-2.6,hsa04915,Estrogen signaling pathway,M111,3,0
1,1,1,-3.6,-2.3,-3.6,R-HSA-8943724,Regulation of PTEN gene transcription,M111,3,0
1,1,1,-6,-5.1,-3.9,R-HSA-187037,Signaling by NTRK1 (TRKA),M111,3,0
1,1,1,-2.8,-5.1,-3.9,GO:0035914,skeletal muscle cell differentiation,M111,3,0
1,1,1,-11,-7.4,-6.8,GO:1903706,regulation of hemopoiesis,M111,3,0
1,1,1,-5.1,-2.5,-3.4,GO:0072089,stem cell proliferation,M111,3,0
1,1,1,-3.2,-3,-2.4,WP2526,PDGF pathway,M111,3,0
1,1,1,-9.1,-5,-3.3,GO:0021543,pallium development,M111,3,0
1,1,1,-3.6,-3.8,-4.5,WP286,IL 3 signaling pathway,M111,3,0
1,1,1,-2.1,-4,-2.2,GO:0021892,cerebral cortex GABAergic interneuron differentiation,M111,3,0
1,1,1,-3.5,-3.2,-2.1,GO:0046651,lymphocyte proliferation,M111,3,0
1,1,1,-6.7,-2.8,-3.4,GO:0050777,negative regulation of immune response,M111,3,0
1,1,1,-4.8,-3.2,-2.2,GO:0032663,regulation of interleukin-2 production,M111,3,0
1,1,1,-2.7,-2.5,-5.1,WP5218,Extrafollicular and follicular B cell activation by SARS CoV 2,M111,3,0
1,1,1,-2.1,-2.1,-2.1,GO:0021781,glial cell fate commitment,M111,3,0
1,1,1,-11,-4.9,-3.4,GO:0051960,regulation of nervous system development,M111,3,0
1,1,1,-2.3,-2.6,-4.8,M175,PID ERBB2 ERBB3 PATHWAY,M111,3,0
1,1,1,-3,-5.1,-3.1,GO:0048339,paraxial mesoderm development,M111,3,0
1,1,1,-6.2,-4.7,-4.1,GO:1902107,positive regulation of leukocyte differentiation,M111,3,0
1,1,1,-4,-3.1,-2.2,hsa04630,JAK-STAT signaling pathway,M111,3,0
1,1,1,-3,-5.1,-2.6,GO:0045666,positive regulation of neuron differentiation,M111,3,0
1,1,1,-2.4,-2.4,-3.3,R-HSA-983705,Signaling by the B Cell Receptor (BCR),M111,3,0
1,1,1,-5,-2.8,-4.6,hsa04650,Natural killer cell mediated cytotoxicity,M111,3,0
1,1,1,-3.9,-2.7,-2.9,GO:0030888,regulation of B cell proliferation,M111,3,0
1,1,1,-7,-2.6,-3.7,GO:0034101,erythrocyte homeostasis,M111,3,0
1,1,1,-2.4,-2.2,-2.1,M151,PID AR TF PATHWAY,M111,3,0
1,1,1,-10,-5.8,-3.5,GO:0006366,transcription by RNA polymerase II,M111,3,0
1,1,1,-13,-3.9,-4.2,hsa05166,Human T-cell leukemia virus 1 infection,M111,3,0
1,1,1,-11,-3.2,-3,M2,PID SMAD2 3NUCLEAR PATHWAY,M111,3,0
1,1,1,-3.1,-3.1,-4,GO:0002763,positive regulation of myeloid leukocyte differentiation,M111,3,0
1,1,1,-5.6,-2.1,-3.5,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",M111,3,0
1,1,1,-6.3,-3.9,-3.5,GO:0048863,stem cell differentiation,M111,3,0
1,1,1,-2.4,-2.2,-2.6,M34,PID TCR PATHWAY,M111,3,0
1,1,1,-3,-4.3,-3,WP4844,Influence of laminopathies on Wnt signaling,M111,3,0
1,1,1,-9.8,-6.4,-7.8,WP23,B cell receptor signaling pathway,M111,3,0
1,1,1,-4.1,-4.5,-2.9,M28,PID IL4 2PATHWAY,M111,3,0
1,1,1,-3,-2.6,-4.9,WP3863,T cell antigen receptor TCR pathway during Staphylococcus aureus infection,M111,3,0
1,1,1,-3.2,-7.6,-3.6,GO:0042472,inner ear morphogenesis,M111,3,0
1,1,1,-5.5,-3.9,-3.7,GO:0002573,myeloid leukocyte differentiation,M111,3,0
1,1,1,-8.1,-4.2,-3.7,GO:0021700,developmental maturation,M111,3,0
1,1,1,-17,-9.2,-7,GO:0045321,leukocyte activation,M111,3,0
1,1,1,-4,-4.6,-4.2,GO:0002761,regulation of myeloid leukocyte differentiation,M111,3,0
1,1,1,-12,-4.3,-2.7,GO:0006351,DNA-templated transcription,M111,3,0
1,1,1,-8.1,-2.8,-2.8,hsa05207,Chemical carcinogenesis - receptor activation,M111,3,0
1,1,1,-4.5,-3.3,-2.9,hsa05221,Acute myeloid leukemia,M111,3,0
1,1,1,-4.4,-3.4,-2.1,hsa05170,Human immunodeficiency virus 1 infection,M111,3,0
1,1,1,-2.1,-2.1,-3.1,GO:0021544,subpallium development,M111,3,0
1,1,1,-3.7,-3.7,-2.6,M186,PID PDGFRB PATHWAY,M111,3,0
1,1,1,-6.4,-2.4,-2.4,GO:1901653,cellular response to peptide,M111,3,0
1,1,1,-4.5,-5.5,-3.7,GO:0071773,cellular response to BMP stimulus,M111,3,0
1,1,1,-4.3,-2.6,-3.2,GO:0046637,regulation of alpha-beta T cell differentiation,M111,3,0
1,1,1,-7.8,-2.6,-2.6,GO:0007623,circadian rhythm,M111,3,0
1,1,1,-3.7,-2,-2.3,WP474,Endochondral ossification,M111,3,0
1,1,1,-4.5,-3.1,-4.9,WP5098,T cell activation SARS CoV 2,M111,3,0
1,1,1,-13,-4,-4.1,GO:0030900,forebrain development,M111,3,0
1,1,1,-2.3,-3.6,-3.5,GO:0046643,regulation of gamma-delta T cell activation,M111,3,0
1,1,1,-2.8,-3.1,-4.1,GO:0046645,positive regulation of gamma-delta T cell activation,M111,3,0
1,1,1,-2.4,-2.4,-3.2,GO:0045588,positive regulation of gamma-delta T cell differentiation,M111,3,0
1,1,1,-3.7,-3.7,-2.3,GO:0031341,regulation of cell killing,M111,3,0
1,1,1,-11,-4,-2.5,GO:0071407,cellular response to organic cyclic compound,M111,3,0
1,1,1,-9.3,-7.7,-3.7,GO:0050678,regulation of epithelial cell proliferation,M111,3,0
1,1,1,-3.7,-2,-2.3,WP4808,Endochondral ossification with skeletal dysplasias,M111,3,0
1,1,1,-4.1,-5.1,-6.2,M183,PID IL6 7 PATHWAY,M111,3,0
1,1,1,-2.7,-3.4,-2.7,GO:0032655,regulation of interleukin-12 production,M111,3,0
1,1,1,-5.8,-2.8,-2.2,GO:0002698,negative regulation of immune effector process,M111,3,0
1,1,1,-10,-3.4,-3.2,GO:0050767,regulation of neurogenesis,M111,3,0
1,1,1,-4.3,-7.7,-4.2,GO:0042471,ear morphogenesis,M111,3,0
1,1,1,-4.7,-3.4,-6.1,hsa04660,T cell receptor signaling pathway,M111,3,0
1,1,1,-4.4,-3.1,-2.7,GO:0021766,hippocampus development,M111,3,0
1,1,1,-4.9,-4.8,-3.2,R-HSA-198725,Nuclear Events (kinase and transcription factor activation),M111,3,0
1,1,1,-7.9,-4,-3.3,GO:0050866,negative regulation of cell activation,M111,3,0
1,1,1,-4.2,-2.5,-3.2,GO:0045444,fat cell differentiation,M111,3,0
1,1,1,-2.1,-3,-3.1,WP313,Hepatocyte growth factor receptor signaling,M111,3,0
1,1,1,-7.7,-11,-5.3,GO:0048562,embryonic organ morphogenesis,M111,3,0
1,1,1,-12,-3,-4.1,hsa05167,Kaposi sarcoma-associated herpesvirus infection,M111,3,0
1,1,1,-7,-2.8,-2,WP289,Myometrial relaxation and contraction pathways,M111,3,0
1,1,1,-18,-4.6,-4.6,GO:0060322,head development,M111,3,0
1,1,1,-7.4,-2.6,-2.5,hsa05163,Human cytomegalovirus infection,M111,3,0
1,1,1,-6.6,-2.6,-2.6,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,M111,3,0
1,1,1,-3.3,-2.8,-2.9,M17200,SA B CELL RECEPTOR COMPLEXES,M111,3,0
1,1,1,-5.2,-3.6,-3.3,GO:0002263,cell activation involved in immune response,M111,3,0
1,1,1,-7.3,-4.3,-3.2,WP2064,Neural crest differentiation,M111,3,0
1,1,1,-9,-5.9,-5.3,R-HSA-449147,Signaling by Interleukins,M111,3,0
1,1,1,-10,-5.9,-4.4,GO:0021537,telencephalon development,M111,3,0
1,1,1,-7.1,-2.7,-2.8,GO:0048872,homeostasis of number of cells,M111,3,0
1,1,1,-4.5,-3.6,-3.1,GO:0060173,limb development,M111,3,0
1,1,1,-2.9,-2.6,-2.2,hsa05210,Colorectal cancer,M111,3,0
1,1,1,-4.9,-4.3,-3,GO:0050868,negative regulation of T cell activation,M111,3,0
1,1,1,-3.5,-3.2,-2.1,GO:0032943,mononuclear cell proliferation,M111,3,0
1,1,1,-4.2,-4.1,-3.9,GO:0045582,positive regulation of T cell differentiation,M111,3,0
1,1,1,-3.1,-4.4,-2.9,R-HSA-8878159,Transcriptional regulation by RUNX3,M111,3,0
1,1,1,-7.7,-2.4,-3.5,GO:0002429,immune response-activating cell surface receptor signaling pathway,M111,3,0
1,1,1,-16,-9.3,-7.7,GO:0046649,lymphocyte activation,M111,3,0
1,1,1,-6.7,-5.1,-5.4,hsa04658,Th1 and Th2 cell differentiation,M111,3,0
1,1,1,-6.1,-3,-4.1,GO:0030218,erythrocyte differentiation,M111,3,0
1,1,1,-6.3,-4.3,-2.1,GO:0007405,neuroblast proliferation,M111,3,0
1,1,1,-10,-7.6,-7.8,GO:0030099,myeloid cell differentiation,M111,3,0
1,1,1,-8.4,-7.4,-2.6,GO:0001701,in utero embryonic development,M111,3,0
1,1,1,-3.9,-4.9,-5,M124,PID CXCR4 PATHWAY,M111,3,0
1,1,1,-8.1,-3,-4,GO:0002768,immune response-regulating cell surface receptor signaling pathway,M111,3,0
1,1,1,-8.3,-3.1,-3.9,GO:0002250,adaptive immune response,M111,3,0
1,1,1,-2.3,-2.6,-2.2,M91,PID TCPTP PATHWAY,M111,3,0
1,1,1,-6,-6.2,-3.8,WP366,TGF beta signaling pathway,M111,3,0
1,1,1,-17,-4.9,-4.2,GO:0007420,brain development,M111,3,0
1,1,1,-4.3,-2.1,-2.3,WP4217,Ebola virus infection in host,M111,3,0
1,1,1,-7.2,-5.7,-5,GO:0045637,regulation of myeloid cell differentiation,M111,3,0
1,1,1,-4.2,-2.6,-3.3,M10,PID BCR 5PATHWAY,M111,3,0
1,1,1,-6.7,-2.7,-3.2,GO:0002757,immune response-activating signaling pathway,M111,3,0
1,1,1,-2.5,-3.9,-2.4,R-HSA-9725370,Signaling by ALK fusions and activated point mutants,M111,3,0
1,1,1,-5.1,-4.2,-2.9,GO:0030326,embryonic limb morphogenesis,M111,3,0
1,1,1,-6.2,-2.4,-2.6,hsa04926,Relaxin signaling pathway,M111,3,0
1,1,1,-5.1,-4.2,-2.9,GO:0035113,embryonic appendage morphogenesis,M111,3,0
1,1,1,-4.4,-3.3,-3.8,GO:0030509,BMP signaling pathway,M111,3,0
1,1,1,-8.4,-4.3,-3.4,hsa04928,"Parathyroid hormone synthesis, secretion and action",M111,3,0
1,1,1,-3.7,-2.8,-2.1,GO:0061515,myeloid cell development,M111,3,0
1,1,1,-7.1,-3.1,-4.6,hsa05215,Prostate cancer,M111,3,0
1,1,1,-8.2,-4.8,-3.1,GO:0002695,negative regulation of leukocyte activation,M111,3,0
1,1,1,-8,-2.4,-4.1,hsa04935,"Growth hormone synthesis, secretion and action",M111,3,0
1,1,1,-11,-4.2,-2.7,GO:0032774,RNA biosynthetic process,M111,3,0
1,1,1,-3.6,-4.2,-2.4,R-HSA-9758941,Gastrulation,M111,3,0
1,1,1,-5.3,-3.2,-2.6,GO:0048663,neuron fate commitment,M111,3,0
1,1,1,-4.4,-4.3,-3.2,GO:0045621,positive regulation of lymphocyte differentiation,M111,3,0
1,1,1,-7.1,-2.3,-2.3,GO:0050728,negative regulation of inflammatory response,M111,3,0
1,1,1,-3.4,-2.4,-2.4,GO:0022029,telencephalon cell migration,M111,3,0
1,1,1,-9.8,-6,-3.2,hsa04380,Osteoclast differentiation,M111,3,0
1,1,1,-7.9,-2.8,-3.7,GO:0031348,negative regulation of defense response,M111,3,0
1,1,1,-3.7,-2.8,-3.9,GO:0002285,lymphocyte activation involved in immune response,M111,3,0
1,1,1,-5.1,-2.7,-3.3,WP5198,Inflammatory bowel disease signaling,M111,3,0
1,1,1,-17,-8.7,-8.3,GO:0001775,cell activation,M111,3,0
1,1,1,-4.8,-3.6,-3.1,GO:0050864,regulation of B cell activation,M111,3,0
1,1,1,-2.3,-4.7,-3.5,M235,PID TCR CALCIUM PATHWAY,M111,3,0
1,1,1,-6.2,-4.7,-4.1,GO:1903708,positive regulation of hemopoiesis,M111,3,0
1,1,1,-2.1,-3,-3.1,R-HSA-2871796,FCERI mediated MAPK activation,M111,3,0
1,1,1,-9,-4.4,-4.2,GO:0050867,positive regulation of cell activation,M111,3,0
1,1,1,-2.3,-3.3,-2.4,WP3937,Microglia pathogen phagocytosis pathway,M111,3,0
1,1,1,-4.2,-4,-3.1,WP3972,PDGFR beta pathway,M111,3,0
1,1,1,-4,-5.1,-4.7,hsa04662,B cell receptor signaling pathway,M111,3,0
1,1,1,-6.5,-3.3,-2.8,GO:0061138,morphogenesis of a branching epithelium,M111,3,0
1,1,1,-4.1,-3.2,-2.8,WP4879,Overlap between signal transduction pathways contributing to LMNA laminopathies,M111,3,0
1,1,1,-7.5,-6,-3.6,R-HSA-9616222,Transcriptional regulation of granulopoiesis,M111,3,0
1,1,1,-12,-5.5,-2.5,hsa05200,Pathways in cancer,M111,3,0
1,1,1,-2.1,-2.7,-2.2,GO:0048340,paraxial mesoderm morphogenesis,M111,3,0
1,1,1,-8,-6.9,-6.2,GO:1902105,regulation of leukocyte differentiation,M111,3,0
1,1,1,-7.6,-3.8,-3.4,WP236,Adipogenesis,M111,3,0
1,1,1,-5.6,-5.2,-2.8,GO:1903038,negative regulation of leukocyte cell-cell adhesion,M111,3,0
1,1,1,-9.2,-5.4,-2.5,GO:0071695,anatomical structure maturation,M111,3,0
1,1,1,-4.8,-4.1,-3.6,WP4659,Gastrin signaling pathway,M111,3,0
1,1,1,-7.3,-5.2,-2.9,GO:0051250,negative regulation of lymphocyte activation,M111,3,0
1,1,1,-10,-6.3,-3.1,GO:0007389,pattern specification process,M111,3,0
1,1,1,-2,-5.2,-2.7,GO:0097154,GABAergic neuron differentiation,M111,3,0
1,1,1,-3,-2.3,-2.3,GO:1902692,regulation of neuroblast proliferation,M111,3,0
1,1,1,-4.9,-2.1,-3.8,GO:0060021,roof of mouth development,M111,3,0
1,1,1,-8.3,-2.7,-3.7,WP4666,Hepatitis B infection,M111,3,0
1,1,1,-4.8,-3.2,-2.8,WP5293,Acute myeloid leukemia,M111,3,0
1,1,1,-4.8,-2.9,-2.8,GO:0002286,T cell activation involved in immune response,M111,3,0
1,1,1,-4.5,-3.7,-2.9,WP4211,Transcriptional cascade regulating adipogenesis,M111,3,0
1,1,1,-8.2,-8.3,-3.7,WP2857,Mesodermal commitment pathway,M111,3,0
1,1,1,-12,-14,-6.5,GO:0048568,embryonic organ development,M111,3,0
1,1,1,-5.2,-4.1,-2.9,GO:0140467,integrated stress response signaling,M111,3,0
1,1,1,-6.7,-2.8,-2.7,GO:0032680,regulation of tumor necrosis factor production,M111,3,0
1,1,1,-5.2,-4.6,-4.2,GO:0045580,regulation of T cell differentiation,M111,3,0
1,1,1,-3.5,-2.5,-2.3,GO:0043433,negative regulation of DNA-binding transcription factor activity,M111,3,0
1,1,1,-3.5,-2.1,-2.7,hsa04668,TNF signaling pathway,M111,3,0
1,1,1,-5.5,-2.6,-3.2,hsa04921,Oxytocin signaling pathway,M111,3,0
1,1,1,-13,-8.2,-6.6,GO:0030098,lymphocyte differentiation,M111,3,0
1,1,1,-2.6,-3.3,-2.3,WP3599,Transcription factor regulation in adipogenesis,M111,3,0
1,1,1,-3.8,-4.3,-3,M272,PID CD8 TCR DOWNSTREAM PATHWAY,M111,3,0
1,1,1,-3.3,-4.7,-2.1,GO:0003151,outflow tract morphogenesis,M111,3,0
1,0,1,-2.3,0,-2.2,R-HSA-9664417,Leishmania phagocytosis,M101,2,0
1,1,0,-3.9,-3.9,0,M65,PID FRA PATHWAY,M110,2,0
1,0,1,-2.3,0,-2.5,GO:0048821,erythrocyte development,M101,2,0
0,1,1,0,-4.2,-4.3,GO:0071417,cellular response to organonitrogen compound,M011,2,0
0,1,1,0,-3.1,-3.6,R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",M011,2,0
0,1,1,0,-2.5,-3.9,GO:0042476,odontogenesis,M011,2,0
1,0,1,-3.4,0,-2,hsa05142,Chagas disease,M101,2,0
0,1,1,0,-3.6,-4,GO:0010001,glial cell differentiation,M011,2,0
1,0,1,-3,0,-2.1,WP4877,Host pathogen interaction of human coronaviruses MAPK signaling,M101,2,0
1,0,1,-3.8,0,-2.2,GO:0032715,negative regulation of interleukin-6 production,M101,2,0
1,1,0,-8,-4.6,0,R-HSA-9006931,Signaling by Nuclear Receptors,M110,2,0
0,1,1,0,-2.9,-2.2,GO:0051345,positive regulation of hydrolase activity,M011,2,0
1,0,1,-3.6,0,-3.4,GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",M101,2,0
1,1,0,-4.4,-2.3,0,GO:0014013,regulation of gliogenesis,M110,2,0
1,1,0,-3.6,-2.6,0,M290,PID IL12 STAT4 PATHWAY,M110,2,0
1,1,0,-3.2,-2.5,0,WP1541,Energy metabolism,M110,2,0
1,1,0,-5.4,-3.8,0,WP5353,A network map of Macrophage stimulating protein MSP signaling,M110,2,0
0,1,1,0,-7.3,-5,R-HSA-1280215,Cytokine Signaling in Immune system,M011,2,0
1,0,1,-2.5,0,-3,GO:0030101,natural killer cell activation,M101,2,0
1,1,0,-2.4,-3.9,0,WP4336,ncRNAs involved in Wnt signaling in hepatocellular carcinoma,M110,2,0
1,0,1,-3.5,0,-3,GO:0046635,positive regulation of alpha-beta T cell activation,M101,2,0
1,1,0,-2.4,-2.2,0,GO:0035019,somatic stem cell population maintenance,M110,2,0
1,1,0,-2.1,-2.7,0,GO:0021902,commitment of neuronal cell to specific neuron type in forebrain,M110,2,0
0,1,1,0,-2.4,-3.2,GO:0032695,negative regulation of interleukin-12 production,M011,2,0
0,1,1,0,-6.9,-2.5,GO:0071345,cellular response to cytokine stimulus,M011,2,0
1,0,1,-3.4,0,-2,R-HSA-202403,TCR signaling,M101,2,0
0,1,1,0,-4.3,-4,GO:0051251,positive regulation of lymphocyte activation,M011,2,0
1,1,0,-2.7,-2.6,0,GO:0048596,embryonic camera-type eye morphogenesis,M110,2,0
1,1,0,-6,-2.2,0,GO:0071222,cellular response to lipopolysaccharide,M110,2,0
1,1,0,-2.4,-2.2,0,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,M110,2,0
1,1,0,-2.9,-2.6,0,GO:0031343,positive regulation of cell killing,M110,2,0
0,1,1,0,-7.8,-4,GO:0035239,tube morphogenesis,M011,2,0
1,0,1,-2.1,0,-2.3,GO:0010324,membrane invagination,M101,2,0
1,1,0,-3.8,-3.7,0,GO:0030183,B cell differentiation,M110,2,0
0,1,1,0,-2.8,-3.5,CORUM:2694,ERG-JUN-FOS DNA-protein complex,M011,2,0
1,0,1,-2.4,0,-2,M22,PID GMCSF PATHWAY,M101,2,0
0,1,1,0,-4.5,-3.3,GO:0043065,positive regulation of apoptotic process,M011,2,0
1,0,1,-2.1,0,-2.2,GO:0016045,detection of bacterium,M101,2,0
1,1,0,-5.7,-3.1,0,GO:2000629,negative regulation of miRNA metabolic process,M110,2,0
1,0,1,-4.2,0,-2.6,hsa04725,Cholinergic synapse,M101,2,0
0,1,1,0,-3.5,-3.6,GO:0060348,bone development,M011,2,0
1,1,0,-6.2,-2.5,0,GO:0050769,positive regulation of neurogenesis,M110,2,0
0,1,1,0,-2.6,-3.7,hsa04664,Fc epsilon RI signaling pathway,M011,2,0
0,1,1,0,-2.7,-2.5,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,M011,2,0
1,1,0,-4.4,-2.5,0,hsa05223,Non-small cell lung cancer,M110,2,0
0,1,1,0,-3.1,-2.3,GO:0032870,cellular response to hormone stimulus,M011,2,0
1,1,0,-3.2,-2.3,0,GO:1902106,negative regulation of leukocyte differentiation,M110,2,0
1,0,1,-2.6,0,-2.9,M8626,SIG BCR SIGNALING PATHWAY,M101,2,0
0,1,1,0,-3.9,-2.8,GO:0045785,positive regulation of cell adhesion,M011,2,0
1,1,0,-2.4,-3,0,GO:0071277,cellular response to calcium ion,M110,2,0
1,0,1,-2.5,0,-2.4,GO:0031342,negative regulation of cell killing,M101,2,0
0,1,1,0,-8.1,-4.6,GO:0060537,muscle tissue development,M011,2,0
1,0,1,-2.1,0,-2.1,WP4871,Kisspeptin kisspeptin receptor system in the ovary,M101,2,0
1,0,1,-2.4,0,-2.9,R-HSA-9674555,Signaling by CSF3 (G-CSF),M101,2,0
0,1,1,0,-8.7,-5.5,GO:0007423,sensory organ development,M011,2,0
0,1,1,0,-3.1,-3.4,GO:0051090,regulation of DNA-binding transcription factor activity,M011,2,0
1,1,0,-5.8,-5,0,R-HSA-8939211,ESR-mediated signaling,M110,2,0
1,0,1,-4,0,-2,WP560,TGF beta receptor signaling,M101,2,0
0,1,1,0,-3.6,-2,GO:0072001,renal system development,M011,2,0
1,0,1,-7.2,0,-6.5,WP3945,TYROBP causal network in microglia,M101,2,0
1,1,0,-6.7,-3.2,0,GO:0048511,rhythmic process,M110,2,0
1,1,0,-5.9,-2.5,0,GO:0001764,neuron migration,M110,2,0
0,1,1,0,-2.6,-3,WP3932,Focal adhesion PI3K Akt mTOR signaling pathway,M011,2,0
1,1,0,-3.8,-3.8,0,WP5373,Role of hypoxia angiogenesis and FGF pathway in OA chondrocyte hypertrophy,M110,2,0
0,1,1,0,-2.1,-2.2,GO:0050680,negative regulation of epithelial cell proliferation,M011,2,0
1,0,1,-5.1,0,-2.8,GO:0006909,phagocytosis,M101,2,0
1,1,0,-3.4,-3.6,0,GO:1901655,cellular response to ketone,M110,2,0
0,1,1,0,-2.5,-2.1,GO:0030593,neutrophil chemotaxis,M011,2,0
1,1,0,-4.3,-2.8,0,WP75,Toll like receptor signaling pathway,M110,2,0
1,1,0,-5,-2.7,0,GO:0045766,positive regulation of angiogenesis,M110,2,0
0,1,1,0,-2.5,-2.1,GO:0001945,lymph vessel development,M011,2,0
1,1,0,-4.2,-5.7,0,GO:0002065,columnar/cuboidal epithelial cell differentiation,M110,2,0
1,1,0,-4,-2,0,GO:0014015,positive regulation of gliogenesis,M110,2,0
1,0,1,-2.6,0,-2.1,WP195,IL 1 signaling pathway,M101,2,0
1,1,0,-2.8,-3.1,0,WP2643,Nanoparticle mediated activation of receptor signaling,M110,2,0
0,1,1,0,-3.6,-3.6,GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,M011,2,0
1,1,0,-2.8,-4.6,0,GO:0002067,glandular epithelial cell differentiation,M110,2,0
0,1,1,0,-2,-2.5,hsa04510,Focal adhesion,M011,2,0
1,0,1,-3.7,0,-2,GO:0051099,positive regulation of binding,M101,2,0
1,1,0,-3.6,-4.1,0,GO:0070664,negative regulation of leukocyte proliferation,M110,2,0
1,1,0,-2.1,-2.1,0,WP4830,GDNF RET signaling axis,M110,2,0
1,0,1,-2.3,0,-2.5,GO:0042092,type 2 immune response,M101,2,0
1,1,0,-3.4,-3.6,0,GO:0032945,negative regulation of mononuclear cell proliferation,M110,2,0
0,1,1,0,-9,-3.4,GO:0030855,epithelial cell differentiation,M011,2,0
1,0,1,-7.9,0,-3,GO:0050808,synapse organization,M101,2,0
1,0,1,-2.6,0,-2.5,GO:0046638,positive regulation of alpha-beta T cell differentiation,M101,2,0
1,1,0,-6.8,-2.2,0,hsa04550,Signaling pathways regulating pluripotency of stem cells,M110,2,0
0,1,1,0,-2.1,-2.3,R-HSA-9607240,FLT3 Signaling,M011,2,0
1,1,0,-2.8,-2.4,0,GO:0042116,macrophage activation,M110,2,0
0,1,1,0,-5.4,-3.8,GO:0001568,blood vessel development,M011,2,0
1,1,0,-3.5,-3.9,0,GO:0051145,smooth muscle cell differentiation,M110,2,0
1,1,0,-4.1,-2.3,0,WP4541,Hippo Merlin signaling dysregulation,M110,2,0
0,1,1,0,-4.4,-3.7,WP5102,Familial partial lipodystrophy,M011,2,0
1,1,0,-10,-10,0,GO:0140747,regulation of ncRNA transcription,M110,2,0
1,0,1,-4.6,0,-3.9,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M101,2,0
1,1,0,-3,-2.3,0,R-HSA-9664433,Leishmania parasite growth and survival,M110,2,0
0,1,1,0,-4.7,-2.1,GO:0019722,calcium-mediated signaling,M011,2,0
0,1,1,0,-3.4,-2.3,GO:0050670,regulation of lymphocyte proliferation,M011,2,0
1,1,0,-3,-3.6,0,WP4223,Ras signaling,M110,2,0
1,1,0,-8.9,-4.6,0,GO:0060562,epithelial tube morphogenesis,M110,2,0
1,1,0,-3.6,-2.8,0,GO:0002704,negative regulation of leukocyte mediated immunity,M110,2,0
0,1,1,0,-3.8,-3.5,GO:0002252,immune effector process,M011,2,0
1,1,0,-2.4,-2.4,0,GO:0010887,negative regulation of cholesterol storage,M110,2,0
1,1,0,-5.3,-2.5,0,WP2853,Endoderm differentiation,M110,2,0
0,1,1,0,-3.2,-3.6,GO:0002764,immune response-regulating signaling pathway,M011,2,0
1,1,0,-2.2,-2.7,0,GO:0071229,cellular response to acid chemical,M110,2,0
1,1,0,-3.2,-2.2,0,GO:0060795,cell fate commitment involved in formation of primary germ layer,M110,2,0
0,1,1,0,-3.2,-2.7,GO:0002703,regulation of leukocyte mediated immunity,M011,2,0
1,0,1,-7.4,0,-2.5,hsa04934,Cushing syndrome,M101,2,0
1,1,0,-2.3,-5.1,0,GO:0003143,embryonic heart tube morphogenesis,M110,2,0
1,1,0,-2.4,-2.2,0,GO:0031076,embryonic camera-type eye development,M110,2,0
1,0,1,-4.2,0,-2.6,GO:0050853,B cell receptor signaling pathway,M101,2,0
1,0,1,-3.1,0,-2.7,WP5174,Ulcerative colitis signaling,M101,2,0
1,0,1,-9,0,-2.9,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,M101,2,0
1,0,1,-2.1,0,-2.3,GO:0099024,plasma membrane invagination,M101,2,0
0,1,1,0,-11,-10,GO:0001501,skeletal system development,M011,2,0
1,0,1,-5.9,0,-2,GO:0001936,regulation of endothelial cell proliferation,M101,2,0
0,1,1,0,-2.4,-2.6,GO:0051155,positive regulation of striated muscle cell differentiation,M011,2,0
1,1,0,-5.2,-2.4,0,GO:0009755,hormone-mediated signaling pathway,M110,2,0
0,1,1,0,-4.6,-3.5,GO:0048514,blood vessel morphogenesis,M011,2,0
1,1,0,-3.1,-2.9,0,hsa04657,IL-17 signaling pathway,M110,2,0
0,1,1,0,-3.4,-2.7,WP3678,Amplification and expansion of oncogenic pathways as metastatic traits,M011,2,0
1,1,0,-3.2,-2.2,0,GO:0032703,negative regulation of interleukin-2 production,M110,2,0
1,0,1,-2.4,0,-2,GO:0098543,detection of other organism,M101,2,0
1,1,0,-4.2,-3.5,0,WP437,EGF EGFR signaling pathway,M110,2,0
1,1,0,-5.3,-2.4,0,WP4255,Non small cell lung cancer,M110,2,0
1,0,1,-4.5,0,-3.6,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M101,2,0
0,1,1,0,-6.4,-6.2,GO:0008283,cell population proliferation,M011,2,0
0,1,1,0,-3.2,-3,GO:0042692,muscle cell differentiation,M011,2,0
0,1,1,0,-2.3,-2.7,M295,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,M011,2,0
0,1,1,0,-4.7,-3,M236,PID DELTA NP63 PATHWAY,M011,2,0
0,1,1,0,-3,-2.4,GO:0010464,regulation of mesenchymal cell proliferation,M011,2,0
1,1,0,-7.5,-2.1,0,GO:0071216,cellular response to biotic stimulus,M110,2,0
0,1,1,0,-2.5,-3.4,hsa05135,Yersinia infection,M011,2,0
0,1,1,0,-3.8,-2.2,GO:0001503,ossification,M011,2,0
0,1,1,0,-2.4,-2.1,GO:0007219,Notch signaling pathway,M011,2,0
1,0,1,-9.8,0,-2.7,WP3594,Circadian rhythm genes,M101,2,0
1,1,0,-4.7,-2.2,0,R-HSA-4090294,SUMOylation of intracellular receptors,M110,2,0
0,1,1,0,-3.9,-3.1,GO:0022409,positive regulation of cell-cell adhesion,M011,2,0
0,1,1,0,-3.5,-4.7,GO:0042475,odontogenesis of dentin-containing tooth,M011,2,0
1,1,0,-4.9,-2.3,0,hsa05152,Tuberculosis,M110,2,0
1,1,0,-2.1,-2.7,0,R-HSA-354192,Integrin signaling,M110,2,0
1,1,0,-2.5,-2.5,0,GO:0002066,columnar/cuboidal epithelial cell development,M110,2,0
1,0,1,-2.1,0,-2.1,GO:0060216,definitive hemopoiesis,M101,2,0
0,1,1,0,-3,-2.2,GO:0070663,regulation of leukocyte proliferation,M011,2,0
1,0,1,-3.9,0,-2.3,M115,PID REG GR PATHWAY,M101,2,0
0,1,1,0,-7.4,-6.2,GO:0061448,connective tissue development,M011,2,0
1,1,0,-3,-2.3,0,R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,M110,2,0
1,1,0,-4.5,-3,0,WP710,DNA damage response only ATM dependent,M110,2,0
0,1,1,0,-2.7,-2.8,R-HSA-1280218,Adaptive Immune System,M011,2,0
0,1,1,0,-3.3,-3,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,M011,2,0
0,1,1,0,-4.7,-2.9,GO:0071353,cellular response to interleukin-4,M011,2,0
1,0,1,-2.4,0,-2,GO:0150079,negative regulation of neuroinflammatory response,M101,2,0
1,1,0,-2.4,-2.2,0,GO:0070301,cellular response to hydrogen peroxide,M110,2,0
1,0,1,-3,0,-2.1,R-HSA-202427,Phosphorylation of CD3 and TCR zeta chains,M101,2,0
0,1,1,0,-2.9,-3.8,GO:1903039,positive regulation of leukocyte cell-cell adhesion,M011,2,0
1,0,1,-3.3,0,-2,GO:0099175,regulation of postsynapse organization,M101,2,0
1,1,0,-3.4,-3.6,0,GO:0050672,negative regulation of lymphocyte proliferation,M110,2,0
0,1,1,0,-5.1,-3.6,GO:0001944,vasculature development,M011,2,0
0,1,1,0,-2.6,-3.5,GO:0006897,endocytosis,M011,2,0
1,0,1,-2.3,0,-2.2,GO:0009595,detection of biotic stimulus,M101,2,0
1,1,0,-3,-2.8,0,GO:0045058,T cell selection,M110,2,0
1,1,0,-4.7,-2.5,0,GO:0048565,digestive tract development,M110,2,0
0,1,1,0,-2.2,-2.3,WP5115,Network map of SARS CoV 2 signaling pathway,M011,2,0
1,0,1,-6.9,0,-2.8,hsa05165,Human papillomavirus infection,M101,2,0
0,1,1,0,-5.7,-3.1,GO:0007507,heart development,M011,2,0
1,0,1,-3.5,0,-3.7,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,M101,2,0
0,1,1,0,-5.1,-5.4,GO:0007167,enzyme-linked receptor protein signaling pathway,M011,2,0
0,1,1,0,-2.6,-5.3,GO:0042063,gliogenesis,M011,2,0
1,0,1,-2.3,0,-2.2,R-HSA-9664422,FCGR3A-mediated phagocytosis,M101,2,0
0,1,1,0,-4.8,-2.4,GO:0090596,sensory organ morphogenesis,M011,2,0
0,1,1,0,-3.5,-3.2,R-HSA-4411364,Binding of TCF/LEF:CTNNB1 to target gene promoters,M011,2,0
1,0,1,-2.4,0,-2.9,WP4585,Cancer immunotherapy by PD 1 blockade,M101,2,0
1,0,1,-2.5,0,-3.3,WP585,Interferon type I signaling pathways,M101,2,0
1,0,1,-5,0,-2.8,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,M101,2,0
1,0,1,-2.9,0,-2.6,GO:0060324,face development,M101,2,0
1,1,0,-4.9,-2.8,0,GO:0045667,regulation of osteoblast differentiation,M110,2,0
0,1,1,0,-2.9,-2.3,WP4172,PI3K Akt signaling pathway,M011,2,0
1,1,0,-2.8,-2.1,0,GO:0045064,T-helper 2 cell differentiation,M110,2,0
1,0,1,-4.9,0,-4.8,GO:0002819,regulation of adaptive immune response,M101,2,0
0,1,1,0,-2.3,-2.3,WP3892,Development of pulmonary dendritic cells and macrophage subsets,M011,2,0
1,1,0,-11,-5.6,0,GO:0071396,cellular response to lipid,M110,2,0
0,1,1,0,-5.5,-2.7,GO:0070670,response to interleukin-4,M011,2,0
0,1,1,0,-4.6,-2.6,GO:0048880,sensory system development,M011,2,0
0,1,1,0,-6.2,-5.3,GO:0048705,skeletal system morphogenesis,M011,2,0
0,1,1,0,-6.1,-5.1,GO:0051216,cartilage development,M011,2,0
1,1,0,-4.3,-2.7,0,GO:0070661,leukocyte proliferation,M110,2,0
1,1,0,-2.9,-2,0,GO:0018212,peptidyl-tyrosine modification,M110,2,0
1,1,0,-2.8,-2.1,0,GO:0032674,regulation of interleukin-5 production,M110,2,0
1,0,1,-2.1,0,-3.5,WP4146,Macrophage markers,M101,2,0
1,0,1,-3,0,-3,R-HSA-2559583,Cellular Senescence,M101,2,0
0,1,1,0,-4.3,-4.4,R-HSA-9006335,Signaling by Erythropoietin,M011,2,0
0,1,1,0,-10,-8.1,GO:0070848,response to growth factor,M011,2,0
1,1,0,-2.1,-2.7,0,GO:0021877,forebrain neuron fate commitment,M110,2,0
0,1,1,0,-8.2,-2.3,GO:0048729,tissue morphogenesis,M011,2,0
0,1,1,0,-3.3,-2.7,hsa05224,Breast cancer,M011,2,0
0,1,1,0,-3.2,-3.6,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,M011,2,0
0,1,1,0,-5.7,-2.2,GO:0003007,heart morphogenesis,M011,2,0
1,1,0,-3.6,-3.1,0,GO:0048048,embryonic eye morphogenesis,M110,2,0
1,1,0,-4.1,-2.7,0,R-HSA-9658195,Leishmania infection,M110,2,0
1,1,0,-2.8,-2.1,0,GO:0034614,cellular response to reactive oxygen species,M110,2,0
1,1,0,-3.9,-2.3,0,GO:0022612,gland morphogenesis,M110,2,0
1,1,0,-6.5,-3.2,0,GO:0051962,positive regulation of nervous system development,M110,2,0
1,1,0,-4.1,-4.5,0,GO:0021988,olfactory lobe development,M110,2,0
1,0,1,-2.1,0,-3.1,R-HSA-186763,Downstream signal transduction,M101,2,0
0,1,1,0,-2.7,-2.4,GO:1902075,cellular response to salt,M011,2,0
0,1,1,0,-2.7,-2.5,GO:0048762,mesenchymal cell differentiation,M011,2,0
1,1,0,-2,-2.8,0,WP2814,Mammary gland development pathway Puberty Stage 2 of 4,M110,2,0
1,0,1,-2.4,0,-2,GO:2001187,"positive regulation of CD8-positive, alpha-beta T cell activation",M101,2,0
1,1,0,-3.6,-2.6,0,GO:0060395,SMAD protein signal transduction,M110,2,0
1,1,0,-6,-2.5,0,GO:0010594,regulation of endothelial cell migration,M110,2,0
0,1,1,0,-4.9,-3.7,GO:0022407,regulation of cell-cell adhesion,M011,2,0
1,1,0,-2.4,-2,0,WP231,TNF alpha signaling pathway,M110,2,0
1,0,1,-3.5,0,-2.2,GO:0032677,regulation of interleukin-8 production,M101,2,0
0,1,1,0,-7.7,-5.2,GO:0045596,negative regulation of cell differentiation,M011,2,0
1,1,0,-5,-2.3,0,WP2374,Oncostatin M signaling pathway,M110,2,0
1,1,0,-4.1,-5.7,0,hsa04062,Chemokine signaling pathway,M110,2,0
0,1,1,0,-2.9,-2.4,WP481,Insulin signaling,M011,2,0
1,1,0,-2.2,-2.2,0,GO:0043406,positive regulation of MAP kinase activity,M110,2,0
1,1,0,-7.9,-3.2,0,WP170,Nuclear receptors,M110,2,0
1,0,1,-2.9,0,-2.6,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,M101,2,0
0,1,1,0,-3.1,-2.3,GO:0051046,regulation of secretion,M011,2,0
0,1,1,0,-5.7,-3.8,GO:0048839,inner ear development,M011,2,0
0,1,1,0,-2.2,-2.4,GO:0050727,regulation of inflammatory response,M011,2,0
1,1,0,-2.2,-2.1,0,GO:0032330,regulation of chondrocyte differentiation,M110,2,0
1,1,0,-4.6,-2.3,0,GO:0001649,osteoblast differentiation,M110,2,0
0,1,1,0,-3.3,-2.3,GO:0030111,regulation of Wnt signaling pathway,M011,2,0
1,1,0,-2.2,-2.1,0,R-HSA-9009391,Extra-nuclear estrogen signaling,M110,2,0
1,0,1,-7.6,0,-4.2,WP5130,Th17 cell differentiation pathway,M101,2,0
1,1,0,-3.6,-2.7,0,GO:0051384,response to glucocorticoid,M110,2,0
0,1,1,0,-3,-2.8,GO:0048871,multicellular organismal-level homeostasis,M011,2,0
1,1,0,-2.3,-2.6,0,M143,PID IL2 PI3K PATHWAY,M110,2,0
0,1,1,0,-2.3,-3.1,GO:0042060,wound healing,M011,2,0
0,1,1,0,-5.2,-3.4,GO:0071559,response to transforming growth factor beta,M011,2,0
1,1,0,-2.4,-3.9,0,WP4155,Endometrial cancer,M110,2,0
1,1,0,-6.4,-2.4,0,hsa04022,cGMP-PKG signaling pathway,M110,2,0
1,1,0,-6.8,-3.9,0,WP706,Sudden infant death syndrome SIDS susceptibility pathways,M110,2,0
0,1,1,0,-3.7,-4,GO:0051147,regulation of muscle cell differentiation,M011,2,0
1,1,0,-2.4,-2.2,0,GO:0090183,regulation of kidney development,M110,2,0
1,1,0,-3.3,-2.7,0,GO:0072132,mesenchyme morphogenesis,M110,2,0
0,1,1,0,-6.2,-4,GO:0001818,negative regulation of cytokine production,M011,2,0
1,1,0,-2.3,-2.6,0,M23,PID WNT NONCANONICAL PATHWAY,M110,2,0
0,1,1,0,-6.4,-5.1,GO:0050865,regulation of cell activation,M011,2,0
1,1,0,-2.4,-2.2,0,GO:0030166,proteoglycan biosynthetic process,M110,2,0
0,1,1,0,-3.9,-2.7,GO:0098727,maintenance of cell number,M011,2,0
0,1,1,0,-4.5,-3.6,GO:0043068,positive regulation of programmed cell death,M011,2,0
1,1,0,-4.3,-2,0,GO:0035710,"CD4-positive, alpha-beta T cell activation",M110,2,0
1,0,1,-5.7,0,-2.3,WP1544,MicroRNAs in cardiomyocyte hypertrophy,M101,2,0
1,0,1,-2.3,0,-2.2,R-HSA-9664407,Parasite infection,M101,2,0
0,1,1,0,-2.6,-2,GO:0030595,leukocyte chemotaxis,M011,2,0
0,1,1,0,-2.6,-2.7,WP306,Focal adhesion,M011,2,0
1,0,1,-4.4,0,-2.1,hsa04927,Cortisol synthesis and secretion,M101,2,0
1,1,0,-5.9,-3.6,0,WP2858,Ectoderm differentiation,M110,2,0
0,1,1,0,-2.8,-3.5,CORUM:2695,ETS2-FOS-JUN complex,M011,2,0
1,0,1,-2.6,0,-2.1,GO:2001222,regulation of neuron migration,M101,2,0
0,1,1,0,-3.1,-2.6,GO:0002253,activation of immune response,M011,2,0
1,1,0,-2.2,-2.3,0,R-HSA-4086398,Ca2+ pathway,M110,2,0
1,1,0,-7.7,-2.1,0,GO:0030522,intracellular receptor signaling pathway,M110,2,0
0,1,1,0,-4.6,-2.4,GO:0001654,eye development,M011,2,0
1,1,0,-3.5,-2.6,0,GO:0021846,cell proliferation in forebrain,M110,2,0
0,1,1,0,-3,-2.7,GO:0051153,regulation of striated muscle cell differentiation,M011,2,0
1,0,1,-4.1,0,-2.1,R-HSA-1912408,Pre-NOTCH Transcription and Translation,M101,2,0
0,1,1,0,-2.1,-3.7,R-HSA-9006925,Intracellular signaling by second messengers,M011,2,0
0,1,1,0,-5.6,-3.7,GO:0045664,regulation of neuron differentiation,M011,2,0
0,1,1,0,-3.6,-4,GO:0050778,positive regulation of immune response,M011,2,0
0,1,1,0,-2.9,-2.4,hsa04151,PI3K-Akt signaling pathway,M011,2,0
1,1,0,-4.5,-2.5,0,hsa04713,Circadian entrainment,M110,2,0
0,1,1,0,-5,-2.5,GO:0043010,camera-type eye development,M011,2,0
1,0,1,-5.1,0,-2.1,hsa04728,Dopaminergic synapse,M101,2,0
0,1,1,0,-2,-2.3,R-HSA-2219528,PI3K/AKT Signaling in Cancer,M011,2,0
1,0,1,-5.1,0,-2.1,GO:0030879,mammary gland development,M101,2,0
1,1,0,-3.6,-3.4,0,WP3967,miR 509 3p alteration of YAP1 ECM axis,M110,2,0
0,1,1,0,-3.7,-4.4,GO:0048704,embryonic skeletal system morphogenesis,M011,2,0
1,0,1,-2.1,0,-2.2,GO:0060333,type II interferon-mediated signaling pathway,M101,2,0
0,1,1,0,-5.3,-3.7,GO:0002683,negative regulation of immune system process,M011,2,0
1,1,0,-3.6,-2.3,0,WP410,Exercise induced circadian regulation,M110,2,0
1,1,0,-2.5,-2.5,0,GO:0010660,regulation of muscle cell apoptotic process,M110,2,0
1,0,1,-5.8,0,-3.1,GO:0002262,myeloid cell homeostasis,M101,2,0
0,1,1,0,-2.8,-3.5,CORUM:2693,NFAT-JUN-FOS DNA-protein complex,M011,2,0
1,1,0,-4.8,-2.3,0,GO:0055123,digestive system development,M110,2,0
1,0,1,-2.3,0,-2.4,hsa04666,Fc gamma R-mediated phagocytosis,M101,2,0
1,0,1,-2.1,0,-2.1,R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,M101,2,0
0,1,1,0,-7.9,-6,WP2849,Hematopoietic stem cell differentiation,M011,2,0
0,1,1,0,-3.3,-2.7,WP4262,Breast cancer pathway,M011,2,0
1,0,1,-4.4,0,-4.4,M7,PID FCER1 PATHWAY,M101,2,0
1,0,1,-5,0,-2.6,R-HSA-168898,Toll-like Receptor Cascades,M101,2,0
1,1,0,-2.7,-2.1,0,GO:0032673,regulation of interleukin-4 production,M110,2,0
1,0,1,-3.1,0,-2.1,R-HSA-421270,Cell-cell junction organization,M101,2,0
1,0,1,-2.7,0,-2.3,GO:0032743,positive regulation of interleukin-2 production,M101,2,0
1,0,1,-3.7,0,-2.3,R-HSA-400253,Circadian Clock,M101,2,0
0,1,1,0,-4.9,-2.9,GO:0007498,mesoderm development,M011,2,0
0,1,1,0,-3.9,-3.8,M206,PID PDGFRA PATHWAY,M011,2,0
1,1,0,-5.1,-2.5,0,GO:1904018,positive regulation of vasculature development,M110,2,0
0,1,1,0,-9.8,-4.4,GO:0009792,embryo development ending in birth or egg hatching,M011,2,0
0,1,1,0,-5.3,-3.2,GO:0006954,inflammatory response,M011,2,0
1,1,0,-6.7,-3,0,GO:0071383,cellular response to steroid hormone stimulus,M110,2,0
1,0,1,-3.6,0,-2.4,R-HSA-1912422,Pre-NOTCH Expression and Processing,M101,2,0
1,0,1,-2.3,0,-2.5,WP1528,Physiological and pathological hypertrophy of the heart,M101,2,0
1,1,0,-2.5,-3.1,0,GO:0032890,regulation of organic acid transport,M110,2,0
1,1,0,-3.6,-2.2,0,GO:1903707,negative regulation of hemopoiesis,M110,2,0
0,1,1,0,-3.7,-3,GO:0022408,negative regulation of cell-cell adhesion,M011,2,0
1,1,0,-4,-5.2,0,GO:0060840,artery development,M110,2,0
1,0,1,-2.4,0,-2,M26,PID NFKAPPAB ATYPICAL PATHWAY,M101,2,0
1,1,0,-5.7,-3.1,0,GO:1902894,negative regulation of miRNA transcription,M110,2,0
1,0,1,-3.8,0,-2.2,GO:0035136,forelimb morphogenesis,M101,2,0
0,1,1,0,-11,-5.4,GO:0048598,embryonic morphogenesis,M011,2,0
0,1,1,0,-5.2,-4,GO:1903037,regulation of leukocyte cell-cell adhesion,M011,2,0
0,1,1,0,-4.2,-3,GO:0048732,gland development,M011,2,0
1,1,0,-2.3,-3.3,0,hsa05213,Endometrial cancer,M110,2,0
0,1,1,0,-5.1,-2.5,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,M011,2,0
0,1,1,0,-5.6,-4.5,GO:0050863,regulation of T cell activation,M011,2,0
1,1,0,-2.6,-2.3,0,GO:0043586,tongue development,M110,2,0
1,1,0,-4.3,-3.6,0,GO:0002520,immune system development,M110,2,0
1,1,0,-3.1,-6.4,0,GO:0035050,embryonic heart tube development,M110,2,0
1,1,0,-3.7,-3.5,0,GO:0035265,organ growth,M110,2,0
1,1,0,-4.4,-4,0,WP2355,Corticotropin releasing hormone signaling pathway,M110,2,0
1,0,1,-2.1,0,-2.1,R-HSA-525793,Myogenesis,M101,2,0
1,1,0,-2.9,-3.2,0,M122,PID IL2 1PATHWAY,M110,2,0
0,1,1,0,-2.2,-2.6,GO:0071241,cellular response to inorganic substance,M011,2,0
0,1,1,0,-2.1,-3.1,GO:0001779,natural killer cell differentiation,M011,2,0
1,0,1,-2.3,0,-2.5,GO:0071425,hematopoietic stem cell proliferation,M101,2,0
1,1,0,-2.7,-2.8,0,WP4542,Leukocyte intrinsic Hippo pathway functions,M110,2,0
1,1,0,-5.1,-2.1,0,M162,PID RXR VDR PATHWAY,M110,2,0
0,1,1,0,-5.9,-7.2,GO:0007517,muscle organ development,M011,2,0
1,1,0,-3.3,-3.5,0,hsa04012,ErbB signaling pathway,M110,2,0
1,1,0,-2,-3.5,0,WP4258,lncRNA in canonical Wnt signaling and colorectal cancer,M110,2,0
1,0,1,-2,0,-2.3,R-HSA-448424,Interleukin-17 signaling,M101,2,0
0,1,1,0,-3.8,-3.3,GO:0019221,cytokine-mediated signaling pathway,M011,2,0
0,1,1,0,-2.8,-3.8,GO:0009611,response to wounding,M011,2,0
1,1,0,-4.7,-3.9,0,GO:0021772,olfactory bulb development,M110,2,0
1,1,0,-8.5,-2.6,0,GO:0046631,alpha-beta T cell activation,M110,2,0
0,1,1,0,-3.3,-2.2,GO:0032944,regulation of mononuclear cell proliferation,M011,2,0
1,1,0,-2.8,-2.3,0,WP3303,RAC1 PAK1 p38 MMP2 pathway,M110,2,0
1,1,0,-6.8,-8.4,0,GO:1902895,positive regulation of miRNA transcription,M110,2,0
1,1,0,-2.6,-4.5,0,GO:0048483,autonomic nervous system development,M110,2,0
1,1,0,-2.6,-3.8,0,GO:0021872,forebrain generation of neurons,M110,2,0
0,1,1,0,-4.2,-4.5,GO:1901699,cellular response to nitrogen compound,M011,2,0
0,1,1,0,-10,-4.6,GO:0043009,chordate embryonic development,M011,2,0
1,1,0,-2.8,-3.3,0,GO:0032526,response to retinoic acid,M110,2,0
1,0,1,-5.7,0,-2.9,GO:0050851,antigen receptor-mediated signaling pathway,M101,2,0
0,1,1,0,-2.6,-2.1,R-HSA-109582,Hemostasis,M011,2,0
1,1,0,-5.1,-2.6,0,GO:0021761,limbic system development,M110,2,0
1,0,1,-4.9,0,-2.2,hsa04730,Long-term depression,M101,2,0
1,1,0,-7.9,-2.3,0,R-HSA-383280,Nuclear Receptor transcription pathway,M110,2,0
1,1,0,-5.9,-2.3,0,GO:0046632,alpha-beta T cell differentiation,M110,2,0
1,1,0,-8.7,-3.7,0,WP3995,Prion disease pathway,M110,2,0
1,1,0,-6.2,-3.5,0,M255,PID HIF1 TFPATHWAY,M110,2,0
1,1,0,-7,-2.8,0,GO:0001656,metanephros development,M110,2,0
1,0,1,-3.8,0,-2.3,GO:0098581,detection of external biotic stimulus,M101,2,0
1,1,0,-3,-2.1,0,GO:0010885,regulation of cholesterol storage,M110,2,0
0,1,1,0,-4.7,-2.6,GO:0150063,visual system development,M011,2,0
1,1,0,-2.1,-2.1,0,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,M110,2,0
1,1,0,-2.9,-2,0,GO:0018108,peptidyl-tyrosine phosphorylation,M110,2,0
0,1,1,0,-2.8,-3.1,GO:0007162,negative regulation of cell adhesion,M011,2,0
1,1,0,-4.9,-2.5,0,GO:0002699,positive regulation of immune effector process,M110,2,0
1,0,1,-2.4,0,-3.6,WP3611,Photodynamic therapy induced AP 1 survival signaling,M101,2,0
1,1,0,-2.2,-2.7,0,R-HSA-9707616,Heme signaling,M110,2,0
1,1,0,-3.9,-2.2,0,hsa04620,Toll-like receptor signaling pathway,M110,2,0
0,1,1,0,-3.8,-2.1,M195,PID CMYB PATHWAY,M011,2,0
1,0,1,-2.6,0,-2.3,GO:0045655,regulation of monocyte differentiation,M101,2,0
0,1,1,0,-8.2,-6.9,GO:0071363,cellular response to growth factor stimulus,M011,2,0
1,1,0,-4.3,-2.2,0,GO:0001708,cell fate specification,M110,2,0
1,1,0,-2.6,-3.1,0,R-HSA-9679191,Potential therapeutics for SARS,M110,2,0
1,1,0,-2.8,-2.1,0,GO:0010888,negative regulation of lipid storage,M110,2,0
1,1,0,-9.9,-9.9,0,GO:1902893,regulation of miRNA transcription,M110,2,0
1,0,1,-2.9,0,-2.6,GO:0043030,regulation of macrophage activation,M101,2,0
1,0,1,-3.2,0,-2.4,GO:0035115,embryonic forelimb morphogenesis,M101,2,0
0,1,1,0,-5.4,-5.1,GO:0002062,chondrocyte differentiation,M011,2,0
0,1,1,0,-2.4,-3.5,WP4205,MET in type 1 papillary renal cell carcinoma,M011,2,0
0,1,1,0,-3,-3.1,GO:0050870,positive regulation of T cell activation,M011,2,0
1,1,0,-3,-2.6,0,WP3931,Embryonic stem cell pluripotency pathways,M110,2,0
0,1,1,0,-2.3,-2.9,GO:0048341,paraxial mesoderm formation,M011,2,0
0,1,1,0,-2.4,-3.2,M193,PID NEPHRIN NEPH1 PATHWAY,M011,2,0
1,1,0,-4.1,-2.7,0,R-HSA-9824443,Parasitic Infection Pathways,M110,2,0
0,1,1,0,-6.1,-3.6,GO:0043583,ear development,M011,2,0
0,1,1,0,-7.2,-5.2,GO:0051249,regulation of lymphocyte activation,M011,2,0
1,1,0,-6.6,-7.4,0,GO:2000630,positive regulation of miRNA metabolic process,M110,2,0
1,1,0,-4.8,-2.6,0,WP127,IL 5 signaling pathway,M110,2,0
1,0,1,-6.4,0,-2.6,hsa05203,Viral carcinogenesis,M101,2,0
1,1,0,-3.8,-5,0,GO:0048639,positive regulation of developmental growth,M110,2,0
0,1,1,0,-3.7,-5,GO:0007519,skeletal muscle tissue development,M011,2,0
0,1,1,0,-2.3,-3,GO:0060326,cell chemotaxis,M011,2,0
1,0,1,-2.7,0,-3.5,GO:0014902,myotube differentiation,M101,2,0
1,1,0,-6.9,-2.3,0,GO:0071219,cellular response to molecule of bacterial origin,M110,2,0
0,1,1,0,-3.9,-4.8,GO:0060538,skeletal muscle organ development,M011,2,0
1,1,0,-4.3,-5.6,0,WP3929,Chemokine signaling pathway,M110,2,0
1,0,1,-2.3,0,-2.2,GO:0043372,"positive regulation of CD4-positive, alpha-beta T cell differentiation",M101,2,0
1,1,0,-2.7,-3.1,0,GO:0060070,canonical Wnt signaling pathway,M110,2,0
0,1,1,0,-5.1,-3.2,GO:0060485,mesenchyme development,M011,2,0
0,1,1,0,-2.4,-2.1,GO:0060041,retina development in camera-type eye,M011,2,0
0,1,1,0,-3.1,-2.9,R-HSA-8951430,RUNX3 regulates WNT signaling,M011,2,0
0,1,1,0,-4.4,-2.5,GO:0071560,cellular response to transforming growth factor beta stimulus,M011,2,0
1,1,0,-4.7,-2.5,0,WP2037,Prolactin signaling pathway,M110,2,0
0,1,1,0,-3.5,-2,R-HSA-8951671,RUNX3 regulates YAP1-mediated transcription,M011,2,0
0,1,1,0,-6.7,-5.6,GO:0002694,regulation of leukocyte activation,M011,2,0
1,0,1,-3.8,0,-2.5,M279,PID RB 1PATHWAY,M101,2,0
1,1,0,-3.1,-2.5,0,GO:0042098,T cell proliferation,M110,2,0
1,1,0,-5.7,-2.1,0,GO:0021987,cerebral cortex development,M110,2,0
0,1,1,0,-3.5,-4.4,GO:0048701,embryonic cranial skeleton morphogenesis,M011,2,0
0,1,1,0,-2.9,-3.3,GO:0010721,negative regulation of cell development,M011,2,0
1,0,1,-3.8,0,-2.2,R-HSA-2871809,FCERI mediated Ca+2 mobilization,M101,2,0
1,1,0,-2.4,-2.4,0,R-HSA-76009,Platelet Aggregation (Plug Formation),M110,2,0
1,1,0,-4.9,-3.7,0,GO:0001892,embryonic placenta development,M110,2,0
0,1,1,0,-8.6,-6.9,GO:0061061,muscle structure development,M011,2,0
1,0,1,-2.3,0,-4,GO:0030890,positive regulation of B cell proliferation,M101,2,0
1,0,1,-5.6,0,-2.7,hsa04211,Longevity regulating pathway,M101,2,0
1,1,0,-3.9,-3.1,0,GO:0033077,T cell differentiation in thymus,M110,2,0
1,1,0,-5.2,-2.7,0,GO:0072091,regulation of stem cell proliferation,M110,2,0
0,1,1,0,-2.5,-2.5,WP1591,Heart development,M011,2,0
1,1,0,-4,-2.2,0,GO:0002718,regulation of cytokine production involved in immune response,M110,2,0
1,1,0,-2.1,-2.5,0,GO:0032653,regulation of interleukin-10 production,M110,2,0
0,1,1,0,-2.8,-4.4,R-HSA-1257604,PIP3 activates AKT signaling,M011,2,0
1,1,0,-9.7,-9,0,GO:2000628,regulation of miRNA metabolic process,M110,2,0
0,1,1,0,-2.4,-3.4,GO:0051146,striated muscle cell differentiation,M011,2,0
1,1,0,-5.8,-3,0,R-HSA-9018519,Estrogen-dependent gene expression,M110,2,0
0,1,1,0,-3.8,-4.6,GO:0002696,positive regulation of leukocyte activation,M011,2,0
1,1,0,-2.1,-2.7,0,CORUM:443,BP-SMAD complex,M110,2,0
1,1,0,-2.4,-2.4,0,GO:0034616,response to laminar fluid shear stress,M110,2,0
0,1,1,0,-3,-4.2,R-HSA-912631,Regulation of signaling by CBL,M011,2,0
0,1,0,0,-2.2,0,R-HSA-983695,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,M010,1,0
0,1,0,0,-2.8,0,GO:0071698,olfactory placode development,M010,1,0
0,1,0,0,-2.3,0,GO:0043380,regulation of memory T cell differentiation,M010,1,0
0,1,0,0,-2.3,0,GO:0072107,positive regulation of ureteric bud formation,M010,1,0
1,0,0,-2,0,0,WP5085,Vasopressin regulated water reabsorption,M100,1,0
0,1,0,0,-2.2,0,GO:0006023,aminoglycan biosynthetic process,M010,1,0
1,0,0,-3.2,0,0,hsa04217,Necroptosis,M100,1,0
1,0,0,-2.5,0,0,GO:0060675,ureteric bud morphogenesis,M100,1,0
1,0,0,-3.7,0,0,WP2586,Aryl hydrocarbon receptor pathway,M100,1,0
0,0,1,0,0,-2.9,R-HSA-450341,Activation of the AP-1 family of transcription factors,M001,1,0
1,0,0,-2.7,0,0,GO:1903350,response to dopamine,M100,1,0
1,0,0,-2.1,0,0,GO:0007413,axonal fasciculation,M100,1,0
0,1,0,0,-2.4,0,GO:0060420,regulation of heart growth,M010,1,0
1,0,0,-3.8,0,0,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,M100,1,0
1,0,0,-2.3,0,0,R-HSA-5607764,CLEC7A (Dectin-1) signaling,M100,1,0
0,1,0,0,-2.1,0,GO:0061043,regulation of vascular wound healing,M010,1,0
1,0,0,-6.8,0,0,WP2324,AGE RAGE pathway,M100,1,0
1,0,0,-4.2,0,0,R-HSA-2424491,DAP12 signaling,M100,1,0
1,0,0,-3.5,0,0,hsa04922,Glucagon signaling pathway,M100,1,0
0,0,1,0,0,-3.5,GO:1901741,positive regulation of myoblast fusion,M001,1,0
1,0,0,-3.3,0,0,GO:0034121,regulation of toll-like receptor signaling pathway,M100,1,0
1,0,0,-2.2,0,0,GO:0002224,toll-like receptor signaling pathway,M100,1,0
1,0,0,-2.3,0,0,GO:1905153,regulation of membrane invagination,M100,1,0
1,0,0,-2,0,0,WP5144,NRP1 triggered signaling pathways in pancreatic cancer,M100,1,0
1,0,0,-4.6,0,0,hsa04710,Circadian rhythm,M100,1,0
1,0,0,-2,0,0,GO:0000271,polysaccharide biosynthetic process,M100,1,0
1,0,0,-3.9,0,0,hsa04932,Non-alcoholic fatty liver disease,M100,1,0
0,1,0,0,-2.4,0,R-HSA-418217,G beta:gamma signalling through PLC beta,M010,1,0
1,0,0,-3.3,0,0,GO:0050852,T cell receptor signaling pathway,M100,1,0
0,0,1,0,0,-2,R-HSA-3858494,Beta-catenin independent WNT signaling,M001,1,0
0,0,1,0,0,-2.1,GO:0032720,negative regulation of tumor necrosis factor production,M001,1,0
1,0,0,-2.6,0,0,GO:0051963,regulation of synapse assembly,M100,1,0
0,1,0,0,-3.1,0,GO:0007512,adult heart development,M010,1,0
1,0,0,-3.9,0,0,WP3858,Toll like receptor signaling related to MyD88,M100,1,0
0,0,1,0,0,-2.5,WP2431,Spinal cord injury,M001,1,0
0,1,0,0,-2.3,0,GO:0045591,positive regulation of regulatory T cell differentiation,M010,1,0
0,1,0,0,-2,0,WP536,Calcium regulation in cardiac cells,M010,1,0
1,0,0,-3.6,0,0,WP254,Apoptosis,M100,1,0
1,0,0,-2.2,0,0,R-HSA-9764260,Regulation of Expression and Function of Type II Classical Cadherins,M100,1,0
1,0,0,-2.4,0,0,hsa05216,Thyroid cancer,M100,1,0
1,0,0,-4.2,0,0,R-HSA-400206,Regulation of lipid metabolism by PPARalpha,M100,1,0
0,0,1,0,0,-2.7,GO:0031646,positive regulation of nervous system process,M001,1,0
1,0,0,-2.1,0,0,GO:0032732,positive regulation of interleukin-1 production,M100,1,0
1,0,0,-3.1,0,0,GO:0042542,response to hydrogen peroxide,M100,1,0
1,0,0,-3.3,0,0,hsa04940,Type I diabetes mellitus,M100,1,0
1,0,0,-3.6,0,0,WP4341,Non genomic actions of 1 25 dihydroxyvitamin D3,M100,1,0
0,1,0,0,-2.1,0,GO:0045577,regulation of B cell differentiation,M010,1,0
0,1,0,0,-2.1,0,R-HSA-397795,G-protein beta:gamma signalling,M010,1,0
1,0,0,-2.1,0,0,GO:0001756,somitogenesis,M100,1,0
0,0,1,0,0,-2.4,GO:0071621,granulocyte chemotaxis,M001,1,0
0,1,0,0,-2.8,0,GO:2000446,regulation of macrophage migration inhibitory factor signaling pathway,M010,1,0
1,0,0,-2.1,0,0,GO:0034135,regulation of toll-like receptor 2 signaling pathway,M100,1,0
0,0,1,0,0,-2,GO:0097530,granulocyte migration,M001,1,0
0,1,0,0,-2.3,0,GO:0033634,positive regulation of cell-cell adhesion mediated by integrin,M010,1,0
0,0,1,0,0,-3.3,GO:0019724,B cell mediated immunity,M001,1,0
0,1,0,0,-2.7,0,GO:1901652,response to peptide,M010,1,0
1,0,0,-3.1,0,0,GO:0061333,renal tubule morphogenesis,M100,1,0
0,1,0,0,-3.3,0,GO:0016055,Wnt signaling pathway,M010,1,0
1,0,0,-2.4,0,0,WP4263,Pancreatic adenocarcinoma pathway,M100,1,0
1,0,0,-2,0,0,GO:0046633,alpha-beta T cell proliferation,M100,1,0
1,0,0,-2,0,0,R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,M100,1,0
0,1,0,0,-3.1,0,GO:0044057,regulation of system process,M010,1,0
1,0,0,-2.1,0,0,WP5397,Vitamin A1 and A5 X pathways,M100,1,0
0,1,0,0,-6.9,0,GO:0008285,negative regulation of cell population proliferation,M010,1,0
0,1,0,0,-2,0,GO:0031099,regeneration,M010,1,0
0,1,0,0,-3.5,0,GO:0001890,placenta development,M010,1,0
0,0,1,0,0,-2,GO:0031032,actomyosin structure organization,M001,1,0
1,0,0,-3.1,0,0,GO:0002503,peptide antigen assembly with MHC class II protein complex,M100,1,0
0,1,0,0,-2.3,0,WP382,MAPK signaling pathway,M010,1,0
1,0,0,-2,0,0,GO:2000679,positive regulation of transcription regulatory region DNA binding,M100,1,0
1,0,0,-2,0,0,GO:0016197,endosomal transport,M100,1,0
1,0,0,-2,0,0,GO:0097152,mesenchymal cell apoptotic process,M100,1,0
0,1,0,0,-3.1,0,GO:0021953,central nervous system neuron differentiation,M010,1,0
1,0,0,-2.2,0,0,GO:0003272,endocardial cushion formation,M100,1,0
1,0,0,-2,0,0,GO:0099170,postsynaptic modulation of chemical synaptic transmission,M100,1,0
1,0,0,-3.7,0,0,GO:0016525,negative regulation of angiogenesis,M100,1,0
0,1,0,0,-4,0,hsa04310,Wnt signaling pathway,M010,1,0
0,0,1,0,0,-2,GO:0010921,regulation of phosphatase activity,M001,1,0
1,0,0,-2.2,0,0,WP4216,Chromosomal and microsatellite instability in colorectal cancer,M100,1,0
0,1,0,0,-2.1,0,GO:0032691,negative regulation of interleukin-1 beta production,M010,1,0
0,1,0,0,-2.2,0,GO:0045670,regulation of osteoclast differentiation,M010,1,0
1,0,0,-2.6,0,0,GO:0030041,actin filament polymerization,M100,1,0
0,0,1,0,0,-3,GO:0051098,regulation of binding,M001,1,0
1,0,0,-2.8,0,0,WP4746,Thyroid hormones production and peripheral downstream signaling effects,M100,1,0
1,0,0,-4.6,0,0,M145,PID P53 DOWNSTREAM PATHWAY,M100,1,0
0,1,0,0,-2.7,0,GO:0060193,positive regulation of lipase activity,M010,1,0
1,0,0,-2.3,0,0,WP4698,Vitamin D sensitive calcium signaling in depression,M100,1,0
1,0,0,-2.1,0,0,WP5273,Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,M100,1,0
1,0,0,-2.6,0,0,hsa05146,Amoebiasis,M100,1,0
1,0,0,-2.2,0,0,GO:0030282,bone mineralization,M100,1,0
0,0,1,0,0,-2.3,WP4564,Neural crest cell migration during development,M001,1,0
1,0,0,-5,0,0,GO:0042594,response to starvation,M100,1,0
1,0,0,-4.3,0,0,GO:0007613,memory,M100,1,0
1,0,0,-2.1,0,0,R-HSA-8951936,RUNX3 regulates p14-ARF,M100,1,0
1,0,0,-2.8,0,0,GO:0050764,regulation of phagocytosis,M100,1,0
1,0,0,-2.2,0,0,GO:0071384,cellular response to corticosteroid stimulus,M100,1,0
1,0,0,-3.8,0,0,WP4482,Vitamin D in inflammatory diseases,M100,1,0
0,1,0,0,-2.4,0,M19,PID P73PATHWAY,M010,1,0
1,0,0,-4,0,0,GO:0045834,positive regulation of lipid metabolic process,M100,1,0
0,0,1,0,0,-2,GO:0097720,calcineurin-mediated signaling,M001,1,0
0,0,1,0,0,-2,GO:0043376,"regulation of CD8-positive, alpha-beta T cell differentiation",M001,1,0
1,0,0,-3,0,0,GO:0072028,nephron morphogenesis,M100,1,0
1,0,0,-2.1,0,0,GO:0033629,negative regulation of cell adhesion mediated by integrin,M100,1,0
1,0,0,-2,0,0,R-HSA-5603041,IRAK4 deficiency (TLR2/4),M100,1,0
1,0,0,-3,0,0,GO:0048546,digestive tract morphogenesis,M100,1,0
0,0,1,0,0,-2,GO:0001934,positive regulation of protein phosphorylation,M001,1,0
1,0,0,-2.1,0,0,hsa04213,Longevity regulating pathway - multiple species,M100,1,0
1,0,0,-3.5,0,0,hsa04911,Insulin secretion,M100,1,0
1,0,0,-2.6,0,0,GO:0120162,positive regulation of cold-induced thermogenesis,M100,1,0
0,0,1,0,0,-2.3,WP4565,Neural crest cell migration in cancer,M001,1,0
1,0,0,-2.3,0,0,M234,PID IL2 STAT5 PATHWAY,M100,1,0
1,0,0,-2.1,0,0,GO:0006766,vitamin metabolic process,M100,1,0
1,0,0,-2.7,0,0,GO:0071548,response to dexamethasone,M100,1,0
1,0,0,-2,0,0,GO:0034505,tooth mineralization,M100,1,0
0,1,0,0,-2.4,0,GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,M010,1,0
0,0,1,0,0,-2.1,hsa04015,Rap1 signaling pathway,M001,1,0
1,0,0,-3.8,0,0,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",M100,1,0
0,1,0,0,-2.7,0,WP2118,Arrhythmogenic right ventricular cardiomyopathy,M010,1,0
0,0,1,0,0,-2,GO:0072109,glomerular mesangium development,M001,1,0
0,1,0,0,-2.2,0,GO:0055013,cardiac muscle cell development,M010,1,0
0,1,0,0,-2.3,0,R-HSA-8866911,TFAP2 (AP-2) family regulates transcription of cell cycle factors,M010,1,0
1,0,0,-2.2,0,0,GO:0015914,phospholipid transport,M100,1,0
0,0,1,0,0,-2,GO:0045190,isotype switching,M001,1,0
0,1,0,0,-3.5,0,GO:0086064,cell communication by electrical coupling involved in cardiac conduction,M010,1,0
0,0,1,0,0,-2.1,GO:0032946,positive regulation of mononuclear cell proliferation,M001,1,0
1,0,0,-3.5,0,0,GO:0062207,regulation of pattern recognition receptor signaling pathway,M100,1,0
1,0,0,-3.8,0,0,WP2011,SREBF and miR33 in cholesterol and lipid homeostasis,M100,1,0
1,0,0,-2,0,0,GO:0071697,ectodermal placode morphogenesis,M100,1,0
0,0,1,0,0,-2.9,GO:0010171,body morphogenesis,M001,1,0
1,0,0,-2.3,0,0,M15,PID LYSOPHOSPHOLIPID PATHWAY,M100,1,0
0,1,0,0,-2.3,0,GO:0055001,muscle cell development,M010,1,0
0,0,1,0,0,-2.4,GO:0006911,"phagocytosis, engulfment",M001,1,0
0,1,0,0,-3.1,0,GO:0045682,regulation of epidermis development,M010,1,0
0,0,1,0,0,-2.1,GO:0000086,G2/M transition of mitotic cell cycle,M001,1,0
0,0,1,0,0,-2.3,GO:0030851,granulocyte differentiation,M001,1,0
1,0,0,-2.1,0,0,WP4136,Fibrin complement receptor 3 signaling pathway,M100,1,0
0,0,1,0,0,-2.4,GO:0043087,regulation of GTPase activity,M001,1,0
1,0,0,-3.7,0,0,R-HSA-975155,MyD88 dependent cascade initiated on endosome,M100,1,0
0,1,0,0,-2.3,0,GO:0044272,sulfur compound biosynthetic process,M010,1,0
1,0,0,-3.6,0,0,GO:0002292,T cell differentiation involved in immune response,M100,1,0
1,0,0,-2,0,0,GO:0070884,regulation of calcineurin-NFAT signaling cascade,M100,1,0
1,0,0,-3.5,0,0,GO:0071868,cellular response to monoamine stimulus,M100,1,0
1,0,0,-2.9,0,0,M1315,SIG PIP3 SIGNALING IN B LYMPHOCYTES,M100,1,0
1,0,0,-2.8,0,0,GO:1990840,response to lectin,M100,1,0
1,0,0,-2.4,0,0,R-HSA-5621481,C-type lectin receptors (CLRs),M100,1,0
1,0,0,-3.1,0,0,WP3298,Melatonin metabolism and effects,M100,1,0
1,0,0,-2.8,0,0,hsa04261,Adrenergic signaling in cardiomyocytes,M100,1,0
1,0,0,-3.8,0,0,GO:0042093,T-helper cell differentiation,M100,1,0
0,1,0,0,-4.1,0,GO:0003206,cardiac chamber morphogenesis,M010,1,0
0,1,0,0,-2.2,0,GO:0060487,lung epithelial cell differentiation,M010,1,0
0,0,1,0,0,-2,R-HSA-8853659,RET signaling,M001,1,0
0,1,0,0,-4.8,0,GO:0014706,striated muscle tissue development,M010,1,0
1,0,0,-3.6,0,0,M92,PID ANGIOPOIETIN RECEPTOR PATHWAY,M100,1,0
1,0,0,-2.5,0,0,WP4685,Melanoma,M100,1,0
0,1,0,0,-2.2,0,WP2895,Differentiation of white and brown adipocyte,M010,1,0
1,0,0,-2.2,0,0,GO:2000142,regulation of DNA-templated transcription initiation,M100,1,0
0,1,0,0,-2.3,0,GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,M010,1,0
0,1,0,0,-3.7,0,GO:0001704,formation of primary germ layer,M010,1,0
1,0,0,-2.4,0,0,WP3657,Hematopoietic stem cell gene regulation by GABP alpha beta complex,M100,1,0
1,0,0,-3.9,0,0,GO:0045622,regulation of T-helper cell differentiation,M100,1,0
1,0,0,-3.8,0,0,R-HSA-112043,PLC beta mediated events,M100,1,0
1,0,0,-4.3,0,0,GO:0062013,positive regulation of small molecule metabolic process,M100,1,0
1,0,0,-2.6,0,0,GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation",M100,1,0
0,1,0,0,-3,0,GO:0050900,leukocyte migration,M010,1,0
1,0,0,-4.7,0,0,hsa05031,Amphetamine addiction,M100,1,0
0,1,0,0,-2.1,0,GO:0001958,endochondral ossification,M010,1,0
1,0,0,-2.2,0,0,hsa05214,Glioma,M100,1,0
0,0,1,0,0,-3.2,GO:1901739,regulation of myoblast fusion,M001,1,0
1,0,0,-2.7,0,0,GO:0030316,osteoclast differentiation,M100,1,0
0,1,0,0,-2,0,GO:2000736,regulation of stem cell differentiation,M010,1,0
1,0,0,-2.7,0,0,GO:0038084,vascular endothelial growth factor signaling pathway,M100,1,0
1,0,0,-2.2,0,0,WP4329,miRNA role in immune response in sepsis,M100,1,0
0,1,0,0,-2.4,0,GO:0002886,regulation of myeloid leukocyte mediated immunity,M010,1,0
0,1,0,0,-2.3,0,GO:0048537,mucosa-associated lymphoid tissue development,M010,1,0
1,0,0,-3.8,0,0,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,M100,1,0
1,0,0,-2.4,0,0,GO:0002716,negative regulation of natural killer cell mediated immunity,M100,1,0
1,0,0,-2.6,0,0,R-HSA-373760,L1CAM interactions,M100,1,0
1,0,0,-3.8,0,0,GO:0001657,ureteric bud development,M100,1,0
0,1,0,0,-2.4,0,R-HSA-392170,ADP signalling through P2Y purinoceptor 12,M010,1,0
0,1,0,0,-2.8,0,GO:0010644,cell communication by electrical coupling,M010,1,0
1,0,0,-2.3,0,0,GO:0032733,positive regulation of interleukin-10 production,M100,1,0
1,0,0,-2.4,0,0,GO:0035264,multicellular organism growth,M100,1,0
1,0,0,-2.9,0,0,hsa04216,Ferroptosis,M100,1,0
1,0,0,-2.8,0,0,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,M100,1,0
0,1,0,0,-2.6,0,R-HSA-9796292,Formation of axial mesoderm,M010,1,0
0,1,0,0,-4.1,0,GO:0048524,positive regulation of viral process,M010,1,0
1,0,0,-2.2,0,0,GO:1903573,negative regulation of response to endoplasmic reticulum stress,M100,1,0
1,0,0,-3.3,0,0,R-HSA-975871,MyD88 cascade initiated on plasma membrane,M100,1,0
0,0,1,0,0,-2.4,hsa01522,Endocrine resistance,M001,1,0
0,1,0,0,-3.3,0,WP2023,Cell differentiation expanded index,M010,1,0
0,1,0,0,-2.1,0,GO:0043301,negative regulation of leukocyte degranulation,M010,1,0
0,0,1,0,0,-2,GO:0035924,cellular response to vascular endothelial growth factor stimulus,M001,1,0
0,1,0,0,-3.5,0,GO:0010518,positive regulation of phospholipase activity,M010,1,0
1,0,0,-2.6,0,0,GO:0045923,positive regulation of fatty acid metabolic process,M100,1,0
1,0,0,-2.9,0,0,GO:0060291,long-term synaptic potentiation,M100,1,0
1,0,0,-4,0,0,GO:0002287,alpha-beta T cell activation involved in immune response,M100,1,0
1,0,0,-2.2,0,0,hsa04540,Gap junction,M100,1,0
0,1,0,0,-2.3,0,GO:0048541,Peyer's patch development,M010,1,0
0,1,0,0,-2.3,0,GO:0014855,striated muscle cell proliferation,M010,1,0
1,0,0,-3.1,0,0,R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling,M100,1,0
0,1,0,0,-2.2,0,WP2880,Glucocorticoid receptor pathway,M010,1,0
1,0,0,-2.4,0,0,GO:0031333,negative regulation of protein-containing complex assembly,M100,1,0
0,1,0,0,-3.3,0,GO:0198738,cell-cell signaling by wnt,M010,1,0
1,0,0,-2.1,0,0,GO:0048617,embryonic foregut morphogenesis,M100,1,0
0,0,1,0,0,-2.9,GO:0002443,leukocyte mediated immunity,M001,1,0
1,0,0,-2.9,0,0,GO:0010883,regulation of lipid storage,M100,1,0
0,1,0,0,-3,0,GO:0003279,cardiac septum development,M010,1,0
0,1,0,0,-2,0,GO:0014033,neural crest cell differentiation,M010,1,0
0,1,0,0,-3.4,0,GO:0003208,cardiac ventricle morphogenesis,M010,1,0
0,0,1,0,0,-2.1,GO:0042481,regulation of odontogenesis,M001,1,0
1,0,0,-2.5,0,0,GO:0035304,regulation of protein dephosphorylation,M100,1,0
1,0,0,-3.8,0,0,GO:0001823,mesonephros development,M100,1,0
1,0,0,-3.7,0,0,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,M100,1,0
1,0,0,-2.2,0,0,GO:0061437,renal system vasculature development,M100,1,0
1,0,0,-2.3,0,0,GO:0008038,neuron recognition,M100,1,0
1,0,0,-3.9,0,0,WP4630,Measles virus infection,M100,1,0
0,0,1,0,0,-2,GO:0044839,cell cycle G2/M phase transition,M001,1,0
1,0,0,-2.2,0,0,GO:0061440,kidney vasculature development,M100,1,0
1,0,0,-2.3,0,0,WP581,EPO receptor signaling,M100,1,0
1,0,0,-2.1,0,0,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,M100,1,0
0,1,0,0,-2.3,0,GO:0071300,cellular response to retinoic acid,M010,1,0
0,1,0,0,-3.7,0,WP2882,Nuclear receptors meta pathway,M010,1,0
1,0,0,-2.3,0,0,GO:0060099,"regulation of phagocytosis, engulfment",M100,1,0
0,1,0,0,-4.7,0,GO:0048589,developmental growth,M010,1,0
0,0,1,0,0,-2.1,GO:0042330,taxis,M001,1,0
1,0,0,-2,0,0,WP2878,PPAR alpha pathway,M100,1,0
0,0,1,0,0,-2.7,GO:0061001,regulation of dendritic spine morphogenesis,M001,1,0
0,0,1,0,0,-2,GO:0030163,protein catabolic process,M001,1,0
0,1,0,0,-5.2,0,GO:0060541,respiratory system development,M010,1,0
1,0,0,-2.3,0,0,R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,M100,1,0
0,1,0,0,-2,0,GO:0031960,response to corticosteroid,M010,1,0
0,1,0,0,-2.3,0,GO:0043305,negative regulation of mast cell degranulation,M010,1,0
0,1,0,0,-3,0,GO:2000177,regulation of neural precursor cell proliferation,M010,1,0
1,0,0,-2.9,0,0,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,M100,1,0
0,1,0,0,-2.3,0,hsa04010,MAPK signaling pathway,M010,1,0
1,0,0,-3,0,0,GO:1905332,positive regulation of morphogenesis of an epithelium,M100,1,0
0,1,0,0,-2.5,0,GO:0048708,astrocyte differentiation,M010,1,0
0,0,1,0,0,-2.3,GO:0002335,mature B cell differentiation,M001,1,0
1,0,0,-3.9,0,0,hsa05330,Allograft rejection,M100,1,0
1,0,0,-2.8,0,0,GO:0048009,insulin-like growth factor receptor signaling pathway,M100,1,0
1,0,0,-4.5,0,0,hsa04916,Melanogenesis,M100,1,0
0,1,0,0,-2.7,0,GO:0045070,positive regulation of viral genome replication,M010,1,0
0,1,0,0,-2.8,0,GO:0060828,regulation of canonical Wnt signaling pathway,M010,1,0
1,0,0,-4.1,0,0,hsa05416,Viral myocarditis,M100,1,0
1,0,0,-2.7,0,0,GO:0097581,lamellipodium organization,M100,1,0
1,0,0,-4.3,0,0,hsa04625,C-type lectin receptor signaling pathway,M100,1,0
1,0,0,-2.8,0,0,GO:0010633,negative regulation of epithelial cell migration,M100,1,0
0,0,1,0,0,-2,GO:1903317,regulation of protein maturation,M001,1,0
1,0,0,-2.3,0,0,GO:0043277,apoptotic cell clearance,M100,1,0
1,0,0,-2.8,0,0,GO:0021542,dentate gyrus development,M100,1,0
1,0,0,-2.3,0,0,R-HSA-982772,Growth hormone receptor signaling,M100,1,0
1,0,0,-2.6,0,0,WP2637,Interleukin 1 IL 1 structural pathway,M100,1,0
0,0,1,0,0,-3.5,GO:0007015,actin filament organization,M001,1,0
0,1,0,0,-5.3,0,GO:0001709,cell fate determination,M010,1,0
1,0,0,-2.2,0,0,hsa04914,Progesterone-mediated oocyte maturation,M100,1,0
1,0,0,-3,0,0,hsa05320,Autoimmune thyroid disease,M100,1,0
1,0,0,-2.4,0,0,GO:0002820,negative regulation of adaptive immune response,M100,1,0
1,0,0,-4.2,0,0,hsa05332,Graft-versus-host disease,M100,1,0
0,1,0,0,-3.1,0,GO:0035051,cardiocyte differentiation,M010,1,0
0,1,0,0,-4.1,0,GO:0002237,response to molecule of bacterial origin,M010,1,0
1,0,0,-2.1,0,0,R-HSA-1234158,Regulation of gene expression by Hypoxia-inducible Factor,M100,1,0
0,1,0,0,-2.7,0,GO:0060191,regulation of lipase activity,M010,1,0
1,0,0,-5.4,0,0,hsa05145,Toxoplasmosis,M100,1,0
1,0,0,-3.3,0,0,hsa04150,mTOR signaling pathway,M100,1,0
1,0,0,-2.1,0,0,R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,M100,1,0
0,1,0,0,-2.3,0,CORUM:2754,JUND-FOSB-SMAD3-SMAD4 complex,M010,1,0
1,0,0,-4.2,0,0,hsa04919,Thyroid hormone signaling pathway,M100,1,0
1,0,0,-4.6,0,0,GO:0010595,positive regulation of endothelial cell migration,M100,1,0
0,0,1,0,0,-3.7,GO:0031644,regulation of nervous system process,M001,1,0
1,0,0,-2.4,0,0,GO:0070371,ERK1 and ERK2 cascade,M100,1,0
0,1,0,0,-2.3,0,GO:0060214,endocardium formation,M010,1,0
1,0,0,-2.2,0,0,GO:0002070,epithelial cell maturation,M100,1,0
0,1,0,0,-2.4,0,GO:0045765,regulation of angiogenesis,M010,1,0
1,0,0,-3.1,0,0,hsa04722,Neurotrophin signaling pathway,M100,1,0
1,0,0,-2.8,0,0,GO:0016322,neuron remodeling,M100,1,0
0,0,1,0,0,-2.8,GO:0030029,actin filament-based process,M001,1,0
0,0,1,0,0,-2.1,GO:0008347,glial cell migration,M001,1,0
1,0,0,-2.1,0,0,GO:0002377,immunoglobulin production,M100,1,0
0,1,0,0,-2,0,GO:0010611,regulation of cardiac muscle hypertrophy,M010,1,0
1,0,0,-2.6,0,0,GO:0090026,positive regulation of monocyte chemotaxis,M100,1,0
1,0,0,-2.3,0,0,GO:0071696,ectodermal placode development,M100,1,0
1,0,0,-2.1,0,0,GO:0036151,phosphatidylcholine acyl-chain remodeling,M100,1,0
1,0,0,-3.8,0,0,GO:0060749,mammary gland alveolus development,M100,1,0
1,0,0,-2,0,0,R-HSA-111933,Calmodulin induced events,M100,1,0
0,1,0,0,-3.3,0,GO:0051048,negative regulation of secretion,M010,1,0
1,0,0,-2.1,0,0,R-HSA-5578775,Ion homeostasis,M100,1,0
1,0,0,-2.7,0,0,GO:0060252,positive regulation of glial cell proliferation,M100,1,0
1,0,0,-3.1,0,0,M50,PID PTP1B PATHWAY,M100,1,0
0,1,0,0,-3.7,0,GO:0010517,regulation of phospholipase activity,M010,1,0
0,1,0,0,-2.6,0,GO:0072189,ureter development,M010,1,0
0,1,0,0,-2.1,0,GO:0060043,regulation of cardiac muscle cell proliferation,M010,1,0
0,0,1,0,0,-2,M278,PID RAC1 PATHWAY,M001,1,0
0,0,1,0,0,-2,R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,M001,1,0
1,0,0,-3.3,0,0,GO:1904036,negative regulation of epithelial cell apoptotic process,M100,1,0
1,0,0,-2.5,0,0,hsa05220,Chronic myeloid leukemia,M100,1,0
1,0,0,-3.6,0,0,GO:0009299,mRNA transcription,M100,1,0
0,1,0,0,-2.6,0,GO:0042474,middle ear morphogenesis,M010,1,0
0,1,0,0,-2.3,0,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,M010,1,0
0,1,0,0,-2.1,0,GO:0045683,negative regulation of epidermis development,M010,1,0
0,1,0,0,-2.3,0,GO:0051924,regulation of calcium ion transport,M010,1,0
1,0,0,-2.9,0,0,GO:0033135,regulation of peptidyl-serine phosphorylation,M100,1,0
0,1,0,0,-3.1,0,GO:0045598,regulation of fat cell differentiation,M010,1,0
0,1,0,0,-2.3,0,GO:0003228,atrial cardiac muscle tissue development,M010,1,0
0,1,0,0,-2,0,GO:0090287,regulation of cellular response to growth factor stimulus,M010,1,0
0,1,0,0,-2.9,0,GO:0071466,cellular response to xenobiotic stimulus,M010,1,0
1,0,0,-4.4,0,0,hsa05032,Morphine addiction,M100,1,0
1,0,0,-2.8,0,0,WP5094,Orexin receptor pathway,M100,1,0
0,0,1,0,0,-2.1,GO:0042832,defense response to protozoan,M001,1,0
1,0,0,-2.1,0,0,GO:0071223,cellular response to lipoteichoic acid,M100,1,0
0,1,0,0,-2.2,0,GO:0048332,mesoderm morphogenesis,M010,1,0
1,0,0,-3,0,0,GO:0071867,response to monoamine,M100,1,0
1,0,0,-2.6,0,0,GO:0014009,glial cell proliferation,M100,1,0
0,1,0,0,-3.3,0,GO:0003231,cardiac ventricle development,M010,1,0
1,0,0,-4.3,0,0,GO:0001938,positive regulation of endothelial cell proliferation,M100,1,0
1,0,0,-9.1,0,0,GO:0050890,cognition,M100,1,0
1,0,0,-2.1,0,0,GO:0045601,regulation of endothelial cell differentiation,M100,1,0
0,1,0,0,-2.6,0,GO:0003158,endothelium development,M010,1,0
0,1,0,0,-2.3,0,GO:0055021,regulation of cardiac muscle tissue growth,M010,1,0
0,0,1,0,0,-2.5,GO:0046532,regulation of photoreceptor cell differentiation,M001,1,0
1,0,0,-3.8,0,0,GO:0002702,positive regulation of production of molecular mediator of immune response,M100,1,0
1,0,0,-2.3,0,0,GO:1904862,inhibitory synapse assembly,M100,1,0
0,1,0,0,-2.3,0,GO:0001570,vasculogenesis,M010,1,0
0,1,0,0,-4.8,0,GO:0035904,aorta development,M010,1,0
0,1,0,0,-2.1,0,GO:0030001,metal ion transport,M010,1,0
0,1,0,0,-3,0,GO:0048745,smooth muscle tissue development,M010,1,0
0,1,0,0,-2.9,0,GO:1900274,regulation of phospholipase C activity,M010,1,0
0,0,1,0,0,-2,R-HSA-2022923,Dermatan sulfate biosynthesis,M001,1,0
1,0,0,-4.4,0,0,hsa05211,Renal cell carcinoma,M100,1,0
0,0,1,0,0,-2.4,GO:0042327,positive regulation of phosphorylation,M001,1,0
1,0,0,-3.1,0,0,GO:0019884,antigen processing and presentation of exogenous antigen,M100,1,0
0,0,1,0,0,-2.2,GO:0050768,negative regulation of neurogenesis,M001,1,0
0,1,0,0,-2.1,0,GO:0045589,regulation of regulatory T cell differentiation,M010,1,0
1,0,0,-3.2,0,0,M161,PID IFNG PATHWAY,M100,1,0
1,0,0,-2.7,0,0,GO:1903351,cellular response to dopamine,M100,1,0
1,0,0,-2.1,0,0,GO:0034122,negative regulation of toll-like receptor signaling pathway,M100,1,0
0,1,0,0,-2.8,0,GO:0071699,olfactory placode morphogenesis,M010,1,0
0,1,0,0,-2.1,0,GO:0035883,enteroendocrine cell differentiation,M010,1,0
0,1,0,0,-2.1,0,GO:0086019,cell-cell signaling involved in cardiac conduction,M010,1,0
1,0,0,-5.2,0,0,GO:0120161,regulation of cold-induced thermogenesis,M100,1,0
1,0,0,-2.3,0,0,GO:0072210,metanephric nephron development,M100,1,0
0,1,0,0,-3.9,0,GO:0021895,cerebral cortex neuron differentiation,M010,1,0
0,1,0,0,-2.9,0,GO:1903900,regulation of viral life cycle,M010,1,0
1,0,0,-2.5,0,0,M233,PID EPO PATHWAY,M100,1,0
1,0,0,-2.7,0,0,GO:0048806,genitalia development,M100,1,0
1,0,0,-2.6,0,0,R-HSA-111996,Ca-dependent events,M100,1,0
1,0,0,-10,0,0,hsa05169,Epstein-Barr virus infection,M100,1,0
0,1,0,0,-2.6,0,GO:2000178,negative regulation of neural precursor cell proliferation,M010,1,0
0,0,1,0,0,-2.7,M1718,SIG IL4RECEPTOR IN B LYPHOCYTES,M001,1,0
1,0,0,-3,0,0,GO:0008286,insulin receptor signaling pathway,M100,1,0
0,1,0,0,-2.3,0,R-HSA-1630316,Glycosaminoglycan metabolism,M010,1,0
0,0,1,0,0,-2.5,GO:0010770,positive regulation of cell morphogenesis,M001,1,0
0,1,0,0,-3.4,0,GO:0032496,response to lipopolysaccharide,M010,1,0
0,1,0,0,-2.3,0,WP5087,Pleural mesothelioma,M010,1,0
0,0,1,0,0,-2.4,GO:0002821,positive regulation of adaptive immune response,M001,1,0
0,0,1,0,0,-2.7,R-HSA-9671555,Signaling by PDGFR in disease,M001,1,0
0,0,1,0,0,-2.5,GO:0050775,positive regulation of dendrite morphogenesis,M001,1,0
1,0,0,-2.1,0,0,R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",M100,1,0
1,0,0,-4,0,0,hsa04931,Insulin resistance,M100,1,0
0,1,0,0,-3.5,0,WP1991,SRF and miRs in smooth muscle differentiation and proliferation,M010,1,0
0,0,1,0,0,-2.3,GO:0043547,positive regulation of GTPase activity,M001,1,0
1,0,0,-2,0,0,GO:0043300,regulation of leukocyte degranulation,M100,1,0
0,1,0,0,-2.8,0,GO:0090103,cochlea morphogenesis,M010,1,0
0,1,0,0,-2.2,0,R-HSA-201681,TCF dependent signaling in response to WNT,M010,1,0
0,1,0,0,-2.6,0,R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,M010,1,0
0,1,0,0,-2.7,0,GO:0032103,positive regulation of response to external stimulus,M010,1,0
1,0,0,-3.8,0,0,WP3680,Physico chemical features and toxicity associated pathways,M100,1,0
1,0,0,-3.7,0,0,hsa04727,GABAergic synapse,M100,1,0
1,0,0,-2.1,0,0,GO:0010745,negative regulation of macrophage derived foam cell differentiation,M100,1,0
1,0,0,-2.1,0,0,GO:0060509,type I pneumocyte differentiation,M100,1,0
0,1,0,0,-2.1,0,GO:0060872,semicircular canal development,M010,1,0
0,0,1,0,0,-2.4,M88,PID CD8 TCR PATHWAY,M001,1,0
1,0,0,-2.2,0,0,GO:0140888,interferon-mediated signaling pathway,M100,1,0
1,0,0,-2.8,0,0,R-HSA-8866910,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,M100,1,0
0,1,0,0,-2.8,0,GO:0045061,thymic T cell selection,M010,1,0
1,0,0,-2.7,0,0,GO:0010596,negative regulation of endothelial cell migration,M100,1,0
0,1,0,0,-2.3,0,GO:0072009,nephron epithelium development,M010,1,0
1,0,0,-2.4,0,0,GO:0098883,synapse pruning,M100,1,0
1,0,0,-3.1,0,0,R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,M100,1,0
1,0,0,-2.1,0,0,WP5202,Alstrom syndrome,M100,1,0
0,0,1,0,0,-2.1,GO:0014904,myotube cell development,M001,1,0
1,0,0,-2.7,0,0,WP1539,Angiogenesis,M100,1,0
0,1,0,0,-3.1,0,GO:0019827,stem cell population maintenance,M010,1,0
0,0,1,0,0,-2.3,R-HSA-1296072,Voltage gated Potassium channels,M001,1,0
0,1,0,0,-2.3,0,GO:1901342,regulation of vasculature development,M010,1,0
1,0,0,-4.3,0,0,hsa04371,Apelin signaling pathway,M100,1,0
1,0,0,-2.4,0,0,GO:0002320,lymphoid progenitor cell differentiation,M100,1,0
0,1,0,0,-2,0,R-HSA-112316,Neuronal System,M010,1,0
1,0,0,-2.4,0,0,GO:0048645,animal organ formation,M100,1,0
0,0,1,0,0,-2.5,GO:2000739,regulation of mesenchymal stem cell differentiation,M001,1,0
1,0,0,-2.4,0,0,WP5205,Clock controlled autophagy in bone metabolism,M100,1,0
1,0,0,-2.7,0,0,GO:0051602,response to electrical stimulus,M100,1,0
0,0,1,0,0,-2.7,GO:0075294,positive regulation by symbiont of entry into host,M001,1,0
1,0,0,-2.4,0,0,R-HSA-8941855,RUNX3 regulates CDKN1A transcription,M100,1,0
1,0,0,-2.9,0,0,GO:0002200,somatic diversification of immune receptors,M100,1,0
1,0,0,-4.8,0,0,GO:0035270,endocrine system development,M100,1,0
0,1,0,0,-2.2,0,GO:0021879,forebrain neuron differentiation,M010,1,0
1,0,0,-2.8,0,0,GO:0150146,cell junction disassembly,M100,1,0
1,0,0,-3.9,0,0,WP4756,Renin angiotensin aldosterone system RAAS,M100,1,0
1,0,0,-2.5,0,0,GO:0045981,positive regulation of nucleotide metabolic process,M100,1,0
1,0,0,-2.1,0,0,M214,PID ERBB1 INTERNALIZATION PATHWAY,M100,1,0
1,0,0,-2.9,0,0,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,M100,1,0
0,0,1,0,0,-3.3,GO:0060325,face morphogenesis,M001,1,0
0,0,1,0,0,-2.7,GO:0046598,positive regulation of viral entry into host cell,M001,1,0
0,1,0,0,-2.2,0,GO:0070588,calcium ion transmembrane transport,M010,1,0
1,0,0,-2.3,0,0,GO:0002501,peptide antigen assembly with MHC protein complex,M100,1,0
1,0,0,-5.8,0,0,GO:0050803,regulation of synapse structure or activity,M100,1,0
0,1,0,0,-2.3,0,GO:0030210,heparin biosynthetic process,M010,1,0
0,1,0,0,-2.1,0,GO:0071248,cellular response to metal ion,M010,1,0
1,0,0,-3.4,0,0,GO:0032649,regulation of type II interferon production,M100,1,0
1,0,0,-2.1,0,0,GO:1905809,negative regulation of synapse organization,M100,1,0
0,0,1,0,0,-2.5,GO:0033173,calcineurin-NFAT signaling cascade,M001,1,0
1,0,0,-3.2,0,0,GO:2000648,positive regulation of stem cell proliferation,M100,1,0
0,0,1,0,0,-2.2,GO:0050671,positive regulation of lymphocyte proliferation,M001,1,0
1,0,0,-2.8,0,0,GO:0072088,nephron epithelium morphogenesis,M100,1,0
1,0,0,-2.4,0,0,hsa05212,Pancreatic cancer,M100,1,0
0,1,0,0,-2.5,0,GO:0007422,peripheral nervous system development,M010,1,0
0,1,0,0,-2.1,0,GO:0070169,positive regulation of biomineral tissue development,M010,1,0
1,0,0,-3.9,0,0,R-HSA-111885,Opioid Signalling,M100,1,0
0,0,1,0,0,-3.2,GO:2000106,regulation of leukocyte apoptotic process,M001,1,0
0,1,0,0,-2.1,0,GO:0001829,trophectodermal cell differentiation,M010,1,0
0,1,0,0,-2.1,0,WP3630,NAD metabolism sirtuins and aging,M010,1,0
1,0,0,-2.2,0,0,GO:0032648,regulation of interferon-beta production,M100,1,0
1,0,0,-3.5,0,0,WP4241,Type 2 papillary renal cell carcinoma,M100,1,0
0,1,0,0,-2.4,0,GO:0048333,mesodermal cell differentiation,M010,1,0
0,0,1,0,0,-2.1,GO:0050766,positive regulation of phagocytosis,M001,1,0
1,0,0,-2.7,0,0,GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,M100,1,0
0,0,1,0,0,-3.2,GO:0060323,head morphogenesis,M001,1,0
0,1,0,0,-2.5,0,GO:0030856,regulation of epithelial cell differentiation,M010,1,0
1,0,0,-3.8,0,0,WP5381,Smith Magenis and Potocki Lupski syndrome copy number variation,M100,1,0
0,1,0,0,-2.6,0,GO:0040018,positive regulation of multicellular organism growth,M010,1,0
1,0,0,-2.5,0,0,GO:1900544,positive regulation of purine nucleotide metabolic process,M100,1,0
0,0,1,0,0,-2,GO:2001224,positive regulation of neuron migration,M001,1,0
1,0,0,-2.1,0,0,R-HSA-1368108,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",M100,1,0
0,1,0,0,-2.3,0,GO:0001707,mesoderm formation,M010,1,0
0,1,0,0,-2.1,0,GO:0021510,spinal cord development,M010,1,0
0,0,1,0,0,-2.3,GO:0098815,modulation of excitatory postsynaptic potential,M001,1,0
0,1,0,0,-2.9,0,GO:0060349,bone morphogenesis,M010,1,0
1,0,0,-3.8,0,0,GO:0061377,mammary gland lobule development,M100,1,0
0,1,0,0,-2.3,0,GO:0007610,behavior,M010,1,0
0,1,0,0,-2.5,0,GO:0014823,response to activity,M010,1,0
0,0,1,0,0,-2.1,GO:0008064,regulation of actin polymerization or depolymerization,M001,1,0
1,0,0,-3.8,0,0,GO:0072163,mesonephric epithelium development,M100,1,0
1,0,0,-3.7,0,0,hsa04613,Neutrophil extracellular trap formation,M100,1,0
0,0,1,0,0,-2.3,R-HSA-9682385,FLT3 signaling in disease,M001,1,0
0,1,0,0,-3.3,0,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,M010,1,0
0,0,1,0,0,-2,GO:0045652,regulation of megakaryocyte differentiation,M001,1,0
1,0,0,-2.5,0,0,GO:1901983,regulation of protein acetylation,M100,1,0
0,0,1,0,0,-2.2,GO:0031396,regulation of protein ubiquitination,M001,1,0
1,0,0,-4.2,0,0,GO:0030902,hindbrain development,M100,1,0
0,1,0,0,-2.3,0,GO:0009629,response to gravity,M010,1,0
1,0,0,-4.3,0,0,hsa04611,Platelet activation,M100,1,0
1,0,0,-2.8,0,0,GO:0002223,stimulatory C-type lectin receptor signaling pathway,M100,1,0
1,0,0,-2.5,0,0,M40,PID E2F PATHWAY,M100,1,0
0,1,0,0,-3.1,0,GO:0045604,regulation of epidermal cell differentiation,M010,1,0
0,1,0,0,-2.1,0,GO:0140115,export across plasma membrane,M010,1,0
1,0,0,-2.7,0,0,GO:0048384,retinoic acid receptor signaling pathway,M100,1,0
1,0,0,-3.6,0,0,WP4816,TGF beta receptor signaling in skeletal dysplasias,M100,1,0
0,1,0,0,-2.6,0,GO:0044706,multi-multicellular organism process,M010,1,0
0,1,0,0,-2.3,0,GO:0031641,regulation of myelination,M010,1,0
0,0,1,0,0,-2.4,GO:0002828,regulation of type 2 immune response,M001,1,0
1,0,0,-3.7,0,0,GO:1990823,response to leukemia inhibitory factor,M100,1,0
1,0,0,-3.9,0,0,GO:0043371,"negative regulation of CD4-positive, alpha-beta T cell differentiation",M100,1,0
1,0,0,-2,0,0,GO:0001658,branching involved in ureteric bud morphogenesis,M100,1,0
0,1,0,0,-2.1,0,GO:0002700,regulation of production of molecular mediator of immune response,M010,1,0
1,0,0,-2.7,0,0,GO:0001569,branching involved in blood vessel morphogenesis,M100,1,0
1,0,0,-3.3,0,0,GO:0071385,cellular response to glucocorticoid stimulus,M100,1,0
0,0,1,0,0,-2.5,GO:0071731,response to nitric oxide,M001,1,0
0,0,1,0,0,-3.5,CORUM:2529,"LAT-PLC-gamma-1-p85-GRB2-CBL-VAV-SLP-76 signaling complex, C305 activated",M001,1,0
1,0,0,-3.3,0,0,WP4396,Nonalcoholic fatty liver disease,M100,1,0
0,1,0,0,-3.7,0,GO:0048638,regulation of developmental growth,M010,1,0
0,0,1,0,0,-2,GO:1905710,positive regulation of membrane permeability,M001,1,0
1,0,0,-2.1,0,0,WP5358,JAK STAT signaling in the regulation of Beta cells,M100,1,0
1,0,0,-4.6,0,0,GO:0043401,steroid hormone mediated signaling pathway,M100,1,0
1,0,0,-2.1,0,0,GO:2000647,negative regulation of stem cell proliferation,M100,1,0
1,0,0,-2.1,0,0,GO:1901862,negative regulation of muscle tissue development,M100,1,0
0,0,1,0,0,-2.9,GO:0071732,cellular response to nitric oxide,M001,1,0
0,0,1,0,0,-2,GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,M001,1,0
0,0,1,0,0,-2.5,GO:0045937,positive regulation of phosphate metabolic process,M001,1,0
1,0,0,-3.1,0,0,WP4481,Resistin as a regulator of inflammation,M100,1,0
1,0,0,-2.2,0,0,R-HSA-977443,GABA receptor activation,M100,1,0
1,0,0,-2.1,0,0,M213,PID AR NONGENOMIC PATHWAY,M100,1,0
1,0,0,-2.4,0,0,R-HSA-9762293,Regulation of CDH11 gene transcription,M100,1,0
1,0,0,-2.1,0,0,GO:0010742,macrophage derived foam cell differentiation,M100,1,0
1,0,0,-3.6,0,0,hsa04218,Cellular senescence,M100,1,0
1,0,0,-2,0,0,hsa04962,Vasopressin-regulated water reabsorption,M100,1,0
0,1,0,0,-2.2,0,R-HSA-9609646,HCMV Infection,M010,1,0
0,1,0,0,-3.2,0,GO:0030324,lung development,M010,1,0
0,1,0,0,-2.2,0,GO:0060045,positive regulation of cardiac muscle cell proliferation,M010,1,0
0,1,0,0,-3.6,0,GO:0003205,cardiac chamber development,M010,1,0
0,1,0,0,-3.6,0,GO:0000902,cell morphogenesis,M010,1,0
0,1,0,0,-2.5,0,GO:0040014,regulation of multicellular organism growth,M010,1,0
1,0,0,-3.6,0,0,R-HSA-2172127,DAP12 interactions,M100,1,0
1,0,0,-4.4,0,0,hsa05030,Cocaine addiction,M100,1,0
0,1,0,0,-2.5,0,GO:0060563,neuroepithelial cell differentiation,M010,1,0
1,0,0,-2.1,0,0,GO:0034198,cellular response to amino acid starvation,M100,1,0
1,0,0,-2.2,0,0,WP2855,Dopaminergic neurogenesis,M100,1,0
0,1,0,0,-3.1,0,GO:0007369,gastrulation,M010,1,0
1,0,0,-6.4,0,0,GO:0048754,branching morphogenesis of an epithelial tube,M100,1,0
0,1,0,0,-2.4,0,GO:0003357,noradrenergic neuron differentiation,M010,1,0
1,0,0,-3,0,0,GO:0042551,neuron maturation,M100,1,0
1,0,0,-2.3,0,0,WP716,Vitamin A and carotenoid metabolism,M100,1,0
1,0,0,-4.7,0,0,M54,PID IL12 2PATHWAY,M100,1,0
1,0,0,-2,0,0,GO:0060100,"positive regulation of phagocytosis, engulfment",M100,1,0
1,0,0,-4.1,0,0,R-HSA-112040,G-protein mediated events,M100,1,0
1,0,0,-3.1,0,0,GO:0032869,cellular response to insulin stimulus,M100,1,0
0,1,0,0,-2.4,0,GO:0043502,regulation of muscle adaptation,M010,1,0
1,0,0,-3,0,0,R-HSA-9664323,FCGR3A-mediated IL10 synthesis,M100,1,0
0,1,0,0,-4.7,0,GO:0040007,growth,M010,1,0
0,1,0,0,-2.3,0,GO:0055007,cardiac muscle cell differentiation,M010,1,0
1,0,0,-2.4,0,0,GO:0033151,V(D)J recombination,M100,1,0
0,1,0,0,-2.9,0,GO:0003015,heart process,M010,1,0
0,1,0,0,-2.3,0,GO:0032693,negative regulation of interleukin-10 production,M010,1,0
0,1,0,0,-2.5,0,GO:0060411,cardiac septum morphogenesis,M010,1,0
0,1,0,0,-2.4,0,GO:0048545,response to steroid hormone,M010,1,0
1,0,0,-6.2,0,0,R-HSA-877300,Interferon gamma signaling,M100,1,0
1,0,0,-3.5,0,0,GO:1990830,cellular response to leukemia inhibitory factor,M100,1,0
1,0,0,-2.1,0,0,GO:0035994,response to muscle stretch,M100,1,0
0,1,0,0,-3,0,GO:0045599,negative regulation of fat cell differentiation,M010,1,0
0,1,0,0,-2.3,0,GO:1904149,regulation of microglial cell mediated cytotoxicity,M010,1,0
1,0,0,-2.2,0,0,GO:0034620,cellular response to unfolded protein,M100,1,0
1,0,0,-2.1,0,0,GO:0014075,response to amine,M100,1,0
1,0,0,-3.5,0,0,R-HSA-5362517,Signaling by Retinoic Acid,M100,1,0
1,0,0,-3.7,0,0,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",M100,1,0
1,0,0,-3.8,0,0,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,M100,1,0
0,0,1,0,0,-2.6,GO:0098657,import into cell,M001,1,0
1,0,0,-2.6,0,0,WP53,ID signaling pathway,M100,1,0
1,0,0,-3,0,0,M210,PID IL8 CXCR2 PATHWAY,M100,1,0
1,0,0,-4.4,0,0,GO:0043535,regulation of blood vessel endothelial cell migration,M100,1,0
1,0,0,-2.6,0,0,M118,PID INTEGRIN A9B1 PATHWAY,M100,1,0
1,0,0,-3.8,0,0,WP2380,Brain derived neurotrophic factor BDNF signaling pathway,M100,1,0
1,0,0,-2.4,0,0,WP4549,Fragile X syndrome,M100,1,0
1,0,0,-2.1,0,0,R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,M100,1,0
0,1,0,0,-3.1,0,R-HSA-157118,Signaling by NOTCH,M010,1,0
1,0,0,-4.3,0,0,GO:0051402,neuron apoptotic process,M100,1,0
0,1,0,0,-3,0,GO:0046622,positive regulation of organ growth,M010,1,0
0,1,0,0,-2.8,0,CORUM:5162,ELK1-SRF-ELK3 complex,M010,1,0
0,1,0,0,-2.1,0,GO:0009855,determination of bilateral symmetry,M010,1,0
1,0,0,-2.3,0,0,R-HSA-210744,Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,M100,1,0
1,0,0,-5.8,0,0,GO:0050807,regulation of synapse organization,M100,1,0
1,0,0,-3,0,0,R-HSA-194138,Signaling by VEGF,M100,1,0
0,1,0,0,-2.1,0,GO:0071599,otic vesicle development,M010,1,0
1,0,0,-2.8,0,0,WP2263,Androgen receptor network in prostate cancer,M100,1,0
0,0,1,0,0,-2.9,GO:0060074,synapse maturation,M001,1,0
1,0,0,-3.4,0,0,GO:0032370,positive regulation of lipid transport,M100,1,0
1,0,0,-3.3,0,0,GO:0007492,endoderm development,M100,1,0
1,0,0,-3.1,0,0,GO:0045600,positive regulation of fat cell differentiation,M100,1,0
1,0,0,-2,0,0,GO:0060788,ectodermal placode formation,M100,1,0
1,0,0,-2.2,0,0,GO:0038093,Fc receptor signaling pathway,M100,1,0
0,1,0,0,-2.8,0,GO:1902869,regulation of amacrine cell differentiation,M010,1,0
0,1,0,0,-2.2,0,GO:0031016,pancreas development,M010,1,0
0,1,0,0,-2.6,0,GO:0043903,regulation of biological process involved in symbiotic interaction,M010,1,0
0,1,0,0,-2.1,0,GO:0042130,negative regulation of T cell proliferation,M010,1,0
1,0,0,-3,0,0,GO:0048864,stem cell development,M100,1,0
0,0,1,0,0,-2,GO:0001562,response to protozoan,M001,1,0
1,0,0,-2,0,0,WP4320,Effect of progerin on genes involved in Hutchinson Gilford progeria syndrome,M100,1,0
1,0,0,-2.1,0,0,R-HSA-1433557,Signaling by SCF-KIT,M100,1,0
1,0,0,-3.3,0,0,GO:0002220,innate immune response activating cell surface receptor signaling pathway,M100,1,0
1,0,0,-3.8,0,0,GO:0001975,response to amphetamine,M100,1,0
0,0,1,0,0,-2,R-HSA-9703465,Signaling by FLT3 fusion proteins,M001,1,0
1,0,0,-2.3,0,0,GO:0007416,synapse assembly,M100,1,0
1,0,0,-2.3,0,0,GO:1904019,epithelial cell apoptotic process,M100,1,0
0,0,1,0,0,-2.3,R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),M001,1,0
1,0,0,-3,0,0,GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,M100,1,0
0,1,0,0,-2.3,0,GO:0003222,ventricular trabecula myocardium morphogenesis,M010,1,0
0,0,1,0,0,-2,R-HSA-73980,RNA Polymerase III Transcription Termination,M001,1,0
0,1,0,0,-2.5,0,GO:0043410,positive regulation of MAPK cascade,M010,1,0
0,0,1,0,0,-2,GO:0030832,regulation of actin filament length,M001,1,0
1,0,0,-2.4,0,0,M169,PID INTEGRIN2 PATHWAY,M100,1,0
0,0,1,0,0,-2.2,GO:0045661,regulation of myoblast differentiation,M001,1,0
0,0,1,0,0,-2.2,GO:0021799,cerebral cortex radially oriented cell migration,M001,1,0
1,0,0,-2.3,0,0,GO:2000319,regulation of T-helper 17 cell differentiation,M100,1,0
1,0,0,-2.1,0,0,GO:0106030,neuron projection fasciculation,M100,1,0
0,1,0,0,-2.2,0,GO:0060479,lung cell differentiation,M010,1,0
1,0,0,-2.3,0,0,WP5422,IL 19 signaling pathway map,M100,1,0
1,0,0,-4.4,0,0,GO:0001961,positive regulation of cytokine-mediated signaling pathway,M100,1,0
1,0,0,-3.1,0,0,GO:0060644,mammary gland epithelial cell differentiation,M100,1,0
1,0,0,-2.3,0,0,M219,PID HEDGEHOG GLI PATHWAY,M100,1,0
1,0,0,-2.7,0,0,GO:0035137,hindlimb morphogenesis,M100,1,0
1,0,0,-3.5,0,0,GO:0031663,lipopolysaccharide-mediated signaling pathway,M100,1,0
1,0,0,-2.6,0,0,GO:0051450,myoblast proliferation,M100,1,0
0,1,0,0,-3.1,0,GO:0007406,negative regulation of neuroblast proliferation,M010,1,0
1,0,0,-2.3,0,0,GO:0021795,cerebral cortex cell migration,M100,1,0
0,0,1,0,0,-2.5,GO:0051149,positive regulation of muscle cell differentiation,M001,1,0
1,0,0,-2.9,0,0,hsa04720,Long-term potentiation,M100,1,0
0,0,1,0,0,-4.1,WP3888,VEGFA VEGFR2 signaling,M001,1,0
1,0,0,-3.8,0,0,WP4674,Head and neck squamous cell carcinoma,M100,1,0
0,0,1,0,0,-2.4,GO:0002706,regulation of lymphocyte mediated immunity,M001,1,0
1,0,0,-2.9,0,0,GO:0021536,diencephalon development,M100,1,0
0,1,0,0,-2.6,0,R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,M010,1,0
1,0,0,-2.8,0,0,hsa03083,Polycomb repressive complex,M100,1,0
0,1,0,0,-3.1,0,GO:0010863,positive regulation of phospholipase C activity,M010,1,0
0,1,0,0,-2.3,0,R-HSA-391160,Signal regulatory protein family interactions,M010,1,0
1,0,0,-3.9,0,0,R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,M100,1,0
0,1,0,0,-4.8,0,GO:0009617,response to bacterium,M010,1,0
0,0,1,0,0,-2.7,GO:0032102,negative regulation of response to external stimulus,M001,1,0
1,0,0,-5,0,0,M254,PID MYC REPRESS PATHWAY,M100,1,0
0,1,0,0,-2.6,0,GO:0014896,muscle hypertrophy,M010,1,0
1,0,0,-2.1,0,0,GO:0010453,regulation of cell fate commitment,M100,1,0
1,0,0,-2,0,0,M110,PID IL1 PATHWAY,M100,1,0
0,0,1,0,0,-2.3,GO:1902742,apoptotic process involved in development,M001,1,0
0,1,0,0,-2.3,0,WP49,IL 2 signaling pathway,M010,1,0
0,1,0,0,-2.9,0,R-HSA-195721,Signaling by WNT,M010,1,0
0,1,0,0,-2.3,0,GO:0044790,suppression of viral release by host,M010,1,0
1,0,0,-2.2,0,0,WP3414,Initiation of transcription and translation elongation at the HIV 1 LTR,M100,1,0
0,1,0,0,-2.2,0,GO:2000179,positive regulation of neural precursor cell proliferation,M010,1,0
1,0,0,-4.4,0,0,GO:0045581,negative regulation of T cell differentiation,M100,1,0
0,0,1,0,0,-2,GO:1903305,regulation of regulated secretory pathway,M001,1,0
1,0,0,-5.3,0,0,hsa05160,Hepatitis C,M100,1,0
0,0,1,0,0,-2.2,GO:0032507,maintenance of protein location in cell,M001,1,0
1,0,0,-2.8,0,0,WP3851,TLR4 signaling and tolerance,M100,1,0
0,1,0,0,-2.1,0,GO:0036075,replacement ossification,M010,1,0
0,1,0,0,-2,0,GO:0071356,cellular response to tumor necrosis factor,M010,1,0
1,0,0,-2.9,0,0,R-HSA-9614085,FOXO-mediated transcription,M100,1,0
0,0,1,0,0,-3.2,GO:0150077,regulation of neuroinflammatory response,M001,1,0
0,0,1,0,0,-2.8,R-HSA-9012999,RHO GTPase cycle,M001,1,0
0,0,1,0,0,-2.2,GO:0051606,detection of stimulus,M001,1,0
1,0,0,-3,0,0,WP4535,Envelope proteins and their potential roles in EDMD physiopathology,M100,1,0
0,1,0,0,-2.3,0,GO:0035905,ascending aorta development,M010,1,0
0,1,0,0,-2.1,0,GO:0070849,response to epidermal growth factor,M010,1,0
1,0,0,-2.7,0,0,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,M100,1,0
1,0,0,-2.1,0,0,GO:0090077,foam cell differentiation,M100,1,0
1,0,0,-2.1,0,0,GO:2000320,negative regulation of T-helper 17 cell differentiation,M100,1,0
0,0,1,0,0,-2,GO:0001738,morphogenesis of a polarized epithelium,M001,1,0
1,0,0,-3.1,0,0,GO:0045669,positive regulation of osteoblast differentiation,M100,1,0
0,0,1,0,0,-2.5,R-HSA-9027284,Erythropoietin activates RAS,M001,1,0
1,0,0,-2.1,0,0,WP5362,TAR syndrome,M100,1,0
0,1,0,0,-2.3,0,GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,M010,1,0
0,1,0,0,-6,0,GO:0045087,innate immune response,M010,1,0
0,0,1,0,0,-2.6,WP4304,Oligodendrocyte specification and differentiation leading to myelin components for CNS,M001,1,0
0,1,0,0,-3,0,GO:0046620,regulation of organ growth,M010,1,0
0,1,0,0,-2.1,0,GO:0030206,chondroitin sulfate biosynthetic process,M010,1,0
1,0,0,-3,0,0,R-HSA-418990,Adherens junctions interactions,M100,1,0
0,0,1,0,0,-2.5,GO:0018107,peptidyl-threonine phosphorylation,M001,1,0
1,0,0,-2.8,0,0,GO:1990858,cellular response to lectin,M100,1,0
0,1,0,0,-3.1,0,R-HSA-9700645,ALK mutants bind TKIs,M010,1,0
1,0,0,-2.5,0,0,GO:0021983,pituitary gland development,M100,1,0
1,0,0,-3.2,0,0,GO:0002861,regulation of inflammatory response to antigenic stimulus,M100,1,0
0,1,0,0,-2.6,0,GO:0010632,regulation of epithelial cell migration,M010,1,0
1,0,0,-3.1,0,0,R-HSA-909733,Interferon alpha/beta signaling,M100,1,0
1,0,0,-4.4,0,0,R-HSA-1500931,Cell-Cell communication,M100,1,0
1,0,0,-3.3,0,0,hsa05164,Influenza A,M100,1,0
0,0,1,0,0,-2.2,GO:0045657,positive regulation of monocyte differentiation,M001,1,0
1,0,0,-3.5,0,0,GO:0019933,cAMP-mediated signaling,M100,1,0
0,0,1,0,0,-3.2,GO:0018210,peptidyl-threonine modification,M001,1,0
0,1,0,0,-4.4,0,GO:0045927,positive regulation of growth,M010,1,0
1,0,0,-2.3,0,0,R-HSA-9614657,FOXO-mediated transcription of cell death genes,M100,1,0
0,1,0,0,-2.5,0,GO:0043408,regulation of MAPK cascade,M010,1,0
0,1,0,0,-2.2,0,GO:1905207,regulation of cardiocyte differentiation,M010,1,0
0,1,0,0,-2.4,0,GO:0042391,regulation of membrane potential,M010,1,0
0,1,0,0,-2.4,0,GO:0010612,regulation of cardiac muscle adaptation,M010,1,0
0,1,0,0,-2.3,0,CORUM:2692,SMAD3-SMAD4-cJun-cFos complex,M010,1,0
1,0,0,-6.1,0,0,GO:0032922,circadian regulation of gene expression,M100,1,0
1,0,0,-2.1,0,0,R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,M100,1,0
1,0,0,-5.9,0,0,GO:0008306,associative learning,M100,1,0
0,0,1,0,0,-2.9,GO:0035771,interleukin-4-mediated signaling pathway,M001,1,0
1,0,0,-2.2,0,0,GO:0033138,positive regulation of peptidyl-serine phosphorylation,M100,1,0
0,1,0,0,-2,0,GO:1903522,regulation of blood circulation,M010,1,0
0,1,0,0,-5.6,0,GO:0035909,aorta morphogenesis,M010,1,0
1,0,0,-2,0,0,WP1545,miRNAs involved in DNA damage response,M100,1,0
1,0,0,-2.4,0,0,R-HSA-1251985,Nuclear signaling by ERBB4,M100,1,0
0,0,1,0,0,-2.3,GO:0051336,regulation of hydrolase activity,M001,1,0
1,0,0,-4.8,0,0,WP5083,Neuroinflammation and glutamatergic signaling,M100,1,0
0,0,1,0,0,-2.2,GO:0032817,regulation of natural killer cell proliferation,M001,1,0
1,0,0,-3.4,0,0,R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,M100,1,0
1,0,0,-2.1,0,0,GO:2000317,negative regulation of T-helper 17 type immune response,M100,1,0
1,0,0,-2.1,0,0,R-HSA-9029558,NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,M100,1,0
0,1,0,0,-2.1,0,R-HSA-9823730,Formation of definitive endoderm,M010,1,0
1,0,0,-3.4,0,0,WP2034,Leptin signaling pathway,M100,1,0
1,0,0,-2.9,0,0,hsa04920,Adipocytokine signaling pathway,M100,1,0
1,0,0,-3.3,0,0,GO:0007249,canonical NF-kappaB signal transduction,M100,1,0
0,1,0,0,-2,0,R-HSA-8986944,Transcriptional Regulation by MECP2,M010,1,0
0,1,0,0,-2.7,0,GO:0060048,cardiac muscle contraction,M010,1,0
0,0,1,0,0,-3.3,GO:0051966,"regulation of synaptic transmission, glutamatergic",M001,1,0
1,0,0,-2.8,0,0,hsa04612,Antigen processing and presentation,M100,1,0
1,0,0,-3.3,0,0,hsa04933,AGE-RAGE signaling pathway in diabetic complications,M100,1,0
1,0,0,-2,0,0,GO:0031100,animal organ regeneration,M100,1,0
1,0,0,-2.9,0,0,WP4331,Neovascularisation processes,M100,1,0
1,0,0,-3.7,0,0,GO:1901343,negative regulation of vasculature development,M100,1,0
1,0,0,-2.6,0,0,GO:0002707,negative regulation of lymphocyte mediated immunity,M100,1,0
0,1,0,0,-2.2,0,hsa05225,Hepatocellular carcinoma,M010,1,0
1,0,0,-4.4,0,0,hsa04917,Prolactin signaling pathway,M100,1,0
1,0,0,-3.3,0,0,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,M100,1,0
1,0,0,-2.3,0,0,GO:0006111,regulation of gluconeogenesis,M100,1,0
1,0,0,-2.1,0,0,GO:0003203,endocardial cushion morphogenesis,M100,1,0
1,0,0,-3.8,0,0,GO:0072164,mesonephric tubule development,M100,1,0
0,1,0,0,-2.1,0,GO:0015012,heparan sulfate proteoglycan biosynthetic process,M010,1,0
1,0,0,-2.5,0,0,hsa04918,Thyroid hormone synthesis,M100,1,0
0,0,1,0,0,-2.4,GO:0033674,positive regulation of kinase activity,M001,1,0
0,1,0,0,-2.1,0,GO:0002467,germinal center formation,M010,1,0
0,1,0,0,-2.3,0,R-HSA-1963640,GRB2 events in ERBB2 signaling,M010,1,0
0,0,1,0,0,-2.5,GO:0090128,regulation of synapse maturation,M001,1,0
1,0,0,-2.2,0,0,GO:1901861,regulation of muscle tissue development,M100,1,0
0,1,0,0,-2.1,0,GO:0009799,specification of symmetry,M010,1,0
1,0,0,-3.6,0,0,hsa04350,TGF-beta signaling pathway,M100,1,0
0,0,1,0,0,-2.2,GO:0030854,positive regulation of granulocyte differentiation,M001,1,0
1,0,0,-2.1,0,0,GO:0032490,detection of molecule of bacterial origin,M100,1,0
0,1,0,0,-3,0,WP4538,Regulatory circuits of the STAT3 signaling pathway,M010,1,0
0,1,0,0,-3.1,0,GO:0051592,response to calcium ion,M010,1,0
1,0,0,-3.3,0,0,GO:0002244,hematopoietic progenitor cell differentiation,M100,1,0
1,0,0,-2.4,0,0,M101,PID HDAC CLASSI PATHWAY,M100,1,0
0,1,0,0,-2.2,0,GO:0070482,response to oxygen levels,M010,1,0
1,0,0,-2.7,0,0,GO:0045648,positive regulation of erythrocyte differentiation,M100,1,0
1,0,0,-2.1,0,0,R-HSA-5607763,CLEC7A (Dectin-1) induces NFAT activation,M100,1,0
1,0,0,-2,0,0,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,M100,1,0
0,0,1,0,0,-2.5,GO:1905563,negative regulation of vascular endothelial cell proliferation,M001,1,0
0,1,0,0,-2.5,0,GO:0071230,cellular response to amino acid stimulus,M010,1,0
1,0,0,-2.6,0,0,GO:0060425,lung morphogenesis,M100,1,0
1,0,0,-2.3,0,0,GO:0003338,metanephros morphogenesis,M100,1,0
0,1,0,0,-2.1,0,GO:1903530,regulation of secretion by cell,M010,1,0
1,0,0,-4.2,0,0,R-HSA-446728,Cell junction organization,M100,1,0
0,0,1,0,0,-2.3,GO:0042100,B cell proliferation,M001,1,0
1,0,0,-3.5,0,0,GO:0031214,biomineral tissue development,M100,1,0
0,1,0,0,-2.3,0,M288,PID HES HEY PATHWAY,M010,1,0
1,0,0,-2.1,0,0,WP5269,Genetic causes of porto sinusoidal vascular disease,M100,1,0
1,0,0,-2.6,0,0,GO:0097242,amyloid-beta clearance,M100,1,0
0,1,0,0,-2.3,0,GO:1903531,negative regulation of secretion by cell,M010,1,0
1,0,0,-2.4,0,0,R-HSA-9759475,Regulation of CDH11 Expression and Function,M100,1,0
1,0,0,-3.3,0,0,hsa05222,Small cell lung cancer,M100,1,0
0,1,0,0,-2,0,GO:0045778,positive regulation of ossification,M010,1,0
0,1,0,0,-7.6,0,GO:0002009,morphogenesis of an epithelium,M010,1,0
1,0,0,-2.7,0,0,GO:0019935,cyclic-nucleotide-mediated signaling,M100,1,0
1,0,0,-3.3,0,0,GO:0046889,positive regulation of lipid biosynthetic process,M100,1,0
0,1,0,0,-2.4,0,GO:0048934,peripheral nervous system neuron differentiation,M010,1,0
0,1,0,0,-2.9,0,GO:0060421,positive regulation of heart growth,M010,1,0
1,0,0,-2.2,0,0,GO:0090162,establishment of epithelial cell polarity,M100,1,0
1,0,0,-2.1,0,0,R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,M100,1,0
1,0,0,-2.5,0,0,WP3942,PPAR signaling pathway,M100,1,0
1,0,0,-2.4,0,0,GO:0002357,defense response to tumor cell,M100,1,0
1,0,0,-2.8,0,0,R-HSA-1362277,Transcription of E2F targets under negative control by DREAM complex,M100,1,0
1,0,0,-4.2,0,0,GO:0060760,positive regulation of response to cytokine stimulus,M100,1,0
1,0,0,-2.6,0,0,hsa04152,AMPK signaling pathway,M100,1,0
1,0,0,-3.2,0,0,WP5072,Modulators of TCR signaling and T cell activation,M100,1,0
1,0,0,-2.2,0,0,M99,PID TXA2PATHWAY,M100,1,0
0,0,1,0,0,-2,GO:0031331,positive regulation of cellular catabolic process,M001,1,0
1,0,0,-2.1,0,0,M32,PID HDAC CLASSIII PATHWAY,M100,1,0
1,0,0,-2.2,0,0,GO:0030225,macrophage differentiation,M100,1,0
1,0,0,-2.4,0,0,R-HSA-381042,PERK regulates gene expression,M100,1,0
0,0,1,0,0,-3.4,GO:0016064,immunoglobulin mediated immune response,M001,1,0
0,0,1,0,0,-2.5,GO:0046533,negative regulation of photoreceptor cell differentiation,M001,1,0
1,0,0,-2.1,0,0,GO:0055057,neuroblast division,M100,1,0
1,0,0,-2.6,0,0,WP5347,IL 26 signaling pathways,M100,1,0
1,0,0,-2,0,0,GO:0043666,regulation of phosphoprotein phosphatase activity,M100,1,0
0,1,0,0,-2.1,0,GO:0045605,negative regulation of epidermal cell differentiation,M010,1,0
1,0,0,-5.1,0,0,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,M100,1,0
1,0,0,-3.5,0,0,GO:0071870,cellular response to catecholamine stimulus,M100,1,0
1,0,0,-3.5,0,0,WP2328,Allograft rejection,M100,1,0
1,0,0,-3.6,0,0,GO:1905954,positive regulation of lipid localization,M100,1,0
1,0,0,-2.6,0,0,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,M100,1,0
0,1,0,0,-2.9,0,GO:0009725,response to hormone,M010,1,0
0,1,0,0,-2.7,0,R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,M010,1,0
1,0,0,-4.3,0,0,GO:0048167,regulation of synaptic plasticity,M100,1,0
0,1,0,0,-2.1,0,GO:0010837,regulation of keratinocyte proliferation,M010,1,0
1,0,0,-4.3,0,0,WP5236,Markers of kidney cell lineage,M100,1,0
0,1,0,0,-2.5,0,GO:0060047,heart contraction,M010,1,0
1,0,0,-3,0,0,GO:1905330,regulation of morphogenesis of an epithelium,M100,1,0
1,0,0,-3.1,0,0,WP2112,IL 17 signaling pathway,M100,1,0
0,1,0,0,-2.1,0,GO:0031589,cell-substrate adhesion,M010,1,0
1,0,0,-4.9,0,0,GO:0043388,positive regulation of DNA binding,M100,1,0
0,1,0,0,-2.2,0,GO:0001101,response to acid chemical,M010,1,0
0,0,1,0,0,-2.8,GO:0060078,regulation of postsynaptic membrane potential,M001,1,0
0,1,0,0,-2.6,0,GO:0072006,nephron development,M010,1,0
0,1,0,0,-3.2,0,GO:0086001,cardiac muscle cell action potential,M010,1,0
0,1,0,0,-3,0,GO:0001947,heart looping,M010,1,0
0,1,0,0,-2.4,0,GO:0048935,peripheral nervous system neuron development,M010,1,0
1,0,0,-3.3,0,0,GO:0060441,epithelial tube branching involved in lung morphogenesis,M100,1,0
0,1,0,0,-2.4,0,GO:0050954,sensory perception of mechanical stimulus,M010,1,0
1,0,0,-2.3,0,0,GO:0002719,negative regulation of cytokine production involved in immune response,M100,1,0
0,0,1,0,0,-2.5,GO:0010562,positive regulation of phosphorus metabolic process,M001,1,0
1,0,0,-3.4,0,0,GO:0060251,regulation of glial cell proliferation,M100,1,0
0,1,0,0,-2.1,0,GO:0098662,inorganic cation transmembrane transport,M010,1,0
1,0,0,-2,0,0,R-HSA-9648895,Response of EIF2AK1 (HRI) to heme deficiency,M100,1,0
1,0,0,-2.1,0,0,GO:0030214,hyaluronan catabolic process,M100,1,0
1,0,0,-2.1,0,0,GO:0097035,regulation of membrane lipid distribution,M100,1,0
0,1,0,0,-2.4,0,GO:0003229,ventricular cardiac muscle tissue development,M010,1,0
0,1,0,0,-2.2,0,GO:0045446,endothelial cell differentiation,M010,1,0
0,1,0,0,-2.2,0,GO:0003300,cardiac muscle hypertrophy,M010,1,0
0,0,1,0,0,-2.2,GO:0060836,lymphatic endothelial cell differentiation,M001,1,0
0,1,0,0,-2.1,0,GO:2000191,regulation of fatty acid transport,M010,1,0
1,0,0,-2,0,0,GO:0030201,heparan sulfate proteoglycan metabolic process,M100,1,0
0,0,1,0,0,-3,GO:0031401,positive regulation of protein modification process,M001,1,0
1,0,0,-3,0,0,WP2817,Mammary gland development pathway Pregnancy and lactation Stage 3 of 4,M100,1,0
1,0,0,-2.3,0,0,M82,PID RET PATHWAY,M100,1,0
0,1,0,0,-3,0,GO:0060350,endochondral bone morphogenesis,M010,1,0
1,0,0,-3,0,0,R-HSA-1489509,DAG and IP3 signaling,M100,1,0
1,0,0,-2.1,0,0,R-HSA-9675126,Diseases of mitotic cell cycle,M100,1,0
0,0,1,0,0,-2.3,hsa05231,Choline metabolism in cancer,M001,1,0
1,0,0,-4.3,0,0,hsa04066,HIF-1 signaling pathway,M100,1,0
0,1,0,0,-3.9,0,GO:0060037,pharyngeal system development,M010,1,0
1,0,0,-2.2,0,0,GO:2000144,positive regulation of DNA-templated transcription initiation,M100,1,0
0,0,1,0,0,-2.9,GO:0002449,lymphocyte mediated immunity,M001,1,0
0,0,1,0,0,-2.3,GO:0031643,positive regulation of myelination,M001,1,0
0,1,0,0,-2.5,0,GO:0060419,heart growth,M010,1,0
0,1,0,0,-2.4,0,GO:1905276,regulation of epithelial tube formation,M010,1,0
1,0,0,-2.5,0,0,GO:0035116,embryonic hindlimb morphogenesis,M100,1,0
0,0,1,0,0,-2.5,GO:2000107,negative regulation of leukocyte apoptotic process,M001,1,0
0,1,0,0,-3.1,0,WP4928,MAPK pathway in congenital thyroid cancer,M010,1,0
0,1,0,0,-2.8,0,GO:0019932,second-messenger-mediated signaling,M010,1,0
1,0,0,-2.1,0,0,GO:0002071,glandular epithelial cell maturation,M100,1,0
1,0,0,-2.1,0,0,CORUM:5233,TNF-alpha/NF-kappa B signaling complex 5,M100,1,0
1,0,0,-4.5,0,0,M105,PID TELOMERASE PATHWAY,M100,1,0
1,0,0,-2.1,0,0,GO:0070391,response to lipoteichoic acid,M100,1,0
0,0,1,0,0,-2.2,GO:0051603,proteolysis involved in protein catabolic process,M001,1,0
1,0,0,-2.4,0,0,GO:0001711,endodermal cell fate commitment,M100,1,0
0,0,1,0,0,-2.2,GO:1903320,regulation of protein modification by small protein conjugation or removal,M001,1,0
0,1,0,0,-3.3,0,GO:0001822,kidney development,M010,1,0
1,0,0,-4.5,0,0,hsa04925,Aldosterone synthesis and secretion,M100,1,0
0,1,0,0,-2.1,0,GO:0097150,neuronal stem cell population maintenance,M010,1,0
0,1,0,0,-2.8,0,GO:0033630,positive regulation of cell adhesion mediated by integrin,M010,1,0
0,1,0,0,-2.2,0,GO:0007605,sensory perception of sound,M010,1,0
0,0,1,0,0,-2.2,R-HSA-2559585,Oncogene Induced Senescence,M001,1,0
1,0,0,-2.2,0,0,GO:0030857,negative regulation of epithelial cell differentiation,M100,1,0
1,0,0,-3,0,0,GO:0071869,response to catecholamine,M100,1,0
0,1,0,0,-4.5,0,GO:0090102,cochlea development,M010,1,0
1,0,0,-2.4,0,0,GO:0043627,response to estrogen,M100,1,0
0,1,0,0,-2.4,0,GO:0002063,chondrocyte development,M010,1,0
0,1,0,0,-2.5,0,M223,PID BETA CATENIN NUC PATHWAY,M010,1,0
0,1,0,0,-2.4,0,GO:0060972,left/right pattern formation,M010,1,0
0,0,1,0,0,-2.5,GO:0007626,locomotory behavior,M001,1,0
1,0,0,-4,0,0,hsa05017,Spinocerebellar ataxia,M100,1,0
1,0,0,-3.4,0,0,GO:0042733,embryonic digit morphogenesis,M100,1,0
0,0,1,0,0,-2,R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,M001,1,0
1,0,0,-2.7,0,0,GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator",M100,1,0
1,0,0,-5.2,0,0,R-HSA-202433,Generation of second messenger molecules,M100,1,0
1,0,0,-2.2,0,0,GO:0072171,mesonephric tubule morphogenesis,M100,1,0
0,1,0,0,-2.1,0,GO:0043200,response to amino acid,M010,1,0
1,0,0,-3.3,0,0,WP3859,TGF beta signaling in thyroid cells for epithelial mesenchymal transition,M100,1,0
0,1,0,0,-2.6,0,GO:0055010,ventricular cardiac muscle tissue morphogenesis,M010,1,0
1,0,0,-2.1,0,0,GO:0002440,production of molecular mediator of immune response,M100,1,0
1,0,0,-2.7,0,0,hsa05322,Systemic lupus erythematosus,M100,1,0
0,1,0,0,-2.1,0,GO:0009612,response to mechanical stimulus,M010,1,0
0,1,0,0,-2.5,0,GO:0006816,calcium ion transport,M010,1,0
1,0,0,-2.5,0,0,R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",M100,1,0
1,0,0,-3.1,0,0,WP3915,Angiopoietin like protein 8 regulatory pathway,M100,1,0
0,0,1,0,0,-2.1,M7955,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,M001,1,0
1,0,0,-4,0,0,GO:0002293,alpha-beta T cell differentiation involved in immune response,M100,1,0
1,0,0,-2.2,0,0,GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M100,1,0
0,1,0,0,-2.6,0,GO:0007224,smoothened signaling pathway,M010,1,0
0,1,0,0,-2.7,0,GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,M010,1,0
1,0,0,-2.2,0,0,R-HSA-9759476,Regulation of Homotypic Cell-Cell Adhesion,M100,1,0
1,0,0,-2.5,0,0,R-HSA-5576891,Cardiac conduction,M100,1,0
1,0,0,-2,0,0,GO:2000379,positive regulation of reactive oxygen species metabolic process,M100,1,0
1,0,0,-2.3,0,0,R-HSA-202430,Translocation of ZAP-70 to Immunological synapse,M100,1,0
1,0,0,-3.5,0,0,GO:0045620,negative regulation of lymphocyte differentiation,M100,1,0
1,0,0,-4.4,0,0,M229,PID P38 ALPHA BETA DOWNSTREAM PATHWAY,M100,1,0
1,0,0,-2.7,0,0,GO:2000772,regulation of cellular senescence,M100,1,0
1,0,0,-3.1,0,0,hsa05323,Rheumatoid arthritis,M100,1,0
1,0,0,-4,0,0,hsa05150,Staphylococcus aureus infection,M100,1,0
0,1,0,0,-2.8,0,GO:0045088,regulation of innate immune response,M010,1,0
0,1,0,0,-2.2,0,GO:0061337,cardiac conduction,M010,1,0
0,1,0,0,-2.8,0,GO:0030910,olfactory placode formation,M010,1,0
0,1,0,0,-3.4,0,GO:0030323,respiratory tube development,M010,1,0
0,1,0,0,-2,0,WP4823,Genes controlling nephrogenesis,M010,1,0
1,0,0,-2.7,0,0,hsa04723,Retrograde endocannabinoid signaling,M100,1,0
0,0,1,0,0,-2,M13,PID ERBB4 PATHWAY,M001,1,0
1,0,0,-2.5,0,0,GO:2000737,negative regulation of stem cell differentiation,M100,1,0
1,0,0,-2.7,0,0,hsa05133,Pertussis,M100,1,0
1,0,0,-6.8,0,0,WP4321,Thermogenesis,M100,1,0
0,0,1,0,0,-2,GO:0031103,axon regeneration,M001,1,0
1,0,0,-4.4,0,0,GO:0032868,response to insulin,M100,1,0
0,1,0,0,-2.8,0,GO:0002076,osteoblast development,M010,1,0
1,0,0,-4.2,0,0,hsa05140,Leishmaniasis,M100,1,0
1,0,0,-3.9,0,0,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,M100,1,0
0,1,0,0,-2.4,0,GO:0043304,regulation of mast cell degranulation,M010,1,0
1,0,0,-2.6,0,0,hsa03320,PPAR signaling pathway,M100,1,0
0,0,1,0,0,-3,GO:0030036,actin cytoskeleton organization,M001,1,0
1,0,0,-3.3,0,0,WP304,Kit receptor signaling pathway,M100,1,0
0,0,1,0,0,-2,GO:1904936,interneuron migration,M001,1,0
1,0,0,-4.4,0,0,WP5417,Cell lineage map for neuronal differentiation,M100,1,0
1,0,0,-3.6,0,0,GO:0071456,cellular response to hypoxia,M100,1,0
0,1,0,0,-2.2,0,hsa04014,Ras signaling pathway,M010,1,0
1,0,0,-2.4,0,0,GO:1900542,regulation of purine nucleotide metabolic process,M100,1,0
1,0,0,-2.3,0,0,CORUM:642,CtBP complex,M100,1,0
0,0,1,0,0,-2.5,GO:0043378,"positive regulation of CD8-positive, alpha-beta T cell differentiation",M001,1,0
0,1,0,0,-2.6,0,GO:0055023,positive regulation of cardiac muscle tissue growth,M010,1,0
1,0,0,-2.2,0,0,R-HSA-4420097,VEGFA-VEGFR2 Pathway,M100,1,0
1,0,0,-2.1,0,0,R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,M100,1,0
1,0,0,-4.3,0,0,WP399,Wnt signaling pathway and pluripotency,M100,1,0
0,1,0,0,-2.8,0,GO:0002831,regulation of response to biotic stimulus,M010,1,0
0,1,0,0,-2.4,0,GO:1903242,regulation of cardiac muscle hypertrophy in response to stress,M010,1,0
0,1,0,0,-2.3,0,R-HSA-451326,Activation of kainate receptors upon glutamate binding,M010,1,0
1,0,0,-2,0,0,GO:0106056,regulation of calcineurin-mediated signaling,M100,1,0
1,0,0,-3.4,0,0,GO:0042789,mRNA transcription by RNA polymerase II,M100,1,0
1,0,0,-2.5,0,0,GO:0045665,negative regulation of neuron differentiation,M100,1,0
1,0,0,-2.1,0,0,GO:0043313,regulation of neutrophil degranulation,M100,1,0
1,0,0,-2.2,0,0,GO:0001937,negative regulation of endothelial cell proliferation,M100,1,0
1,0,0,-2.6,0,0,GO:0045623,negative regulation of T-helper cell differentiation,M100,1,0
1,0,0,-2.1,0,0,R-HSA-139915,Activation of PUMA and translocation to mitochondria,M100,1,0
0,1,0,0,-2.5,0,GO:0043122,regulation of canonical NF-kappaB signal transduction,M010,1,0
0,1,0,0,-2.6,0,M30,PID HDAC CLASSII PATHWAY,M010,1,0
0,1,0,0,-2.2,0,GO:0014897,striated muscle hypertrophy,M010,1,0
0,1,0,0,-2.1,0,GO:0021516,dorsal spinal cord development,M010,1,0
1,0,0,-3.4,0,0,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,M100,1,0
1,0,0,-3.8,0,0,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,M100,1,0
1,0,0,-2.1,0,0,GO:0031000,response to caffeine,M100,1,0
1,0,0,-2.2,0,0,GO:0002639,positive regulation of immunoglobulin production,M100,1,0
0,1,0,0,-2.3,0,R-HSA-2990846,SUMOylation,M010,1,0
0,1,0,0,-2.1,0,hsa00532,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,M010,1,0
0,1,0,0,-2.5,0,WP2873,Aryl hydrocarbon receptor pathway,M010,1,0
0,1,0,0,-2.1,0,GO:0051412,response to corticosterone,M010,1,0
0,1,0,0,-2.5,0,GO:0046596,regulation of viral entry into host cell,M010,1,0
1,0,0,-2.7,0,0,GO:0008154,actin polymerization or depolymerization,M100,1,0
1,0,0,-2.6,0,0,R-HSA-8853884,Transcriptional Regulation by VENTX,M100,1,0
1,0,0,-2,0,0,GO:0090398,cellular senescence,M100,1,0
1,0,0,-3.2,0,0,WP2795,Cardiac hypertrophic response,M100,1,0
0,1,0,0,-2.5,0,GO:0034341,response to type II interferon,M010,1,0
1,0,0,-3.1,0,0,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,M100,1,0
1,0,0,-3.1,0,0,GO:0009880,embryonic pattern specification,M100,1,0
1,0,0,-2.1,0,0,GO:0006112,energy reserve metabolic process,M100,1,0
1,0,0,-3.3,0,0,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,M100,1,0
1,0,0,-2.8,0,0,GO:0043255,regulation of carbohydrate biosynthetic process,M100,1,0
1,0,0,-3,0,0,GO:0032757,positive regulation of interleukin-8 production,M100,1,0
1,0,0,-3.1,0,0,GO:0002399,MHC class II protein complex assembly,M100,1,0
0,1,0,0,-2.3,0,GO:0052372,modulation by symbiont of entry into host,M010,1,0
1,0,0,-2.1,0,0,GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,M100,1,0
0,1,0,0,-2.3,0,WP5092,Interactions of natural killer cells in pancreatic cancer,M010,1,0
0,0,1,0,0,-2.5,GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",M001,1,0
1,0,0,-3.3,0,0,GO:0002478,antigen processing and presentation of exogenous peptide antigen,M100,1,0
0,1,0,0,-2.3,0,GO:0035910,ascending aorta morphogenesis,M010,1,0
1,0,0,-4.7,0,0,WP3584,MECP2 and associated Rett syndrome,M100,1,0
1,0,0,-4.9,0,0,WP2203,Thymic stromal lymphopoietin TSLP signaling pathway,M100,1,0
0,1,0,0,-2.2,0,WP5395,Glycosaminoglycan synthesis in fibroblasts,M010,1,0
0,1,0,0,-2.2,0,R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,M010,1,0
1,0,0,-3.1,0,0,GO:0044321,response to leptin,M100,1,0
0,0,1,0,0,-2.4,GO:0001914,regulation of T cell mediated cytotoxicity,M001,1,0
1,0,0,-2,0,0,WP2261,Glioblastoma signaling pathways,M100,1,0
1,0,0,-2.1,0,0,GO:0051932,"synaptic transmission, GABAergic",M100,1,0
1,0,0,-2.1,0,0,R-HSA-381119,Unfolded Protein Response (UPR),M100,1,0
0,0,1,0,0,-2.5,GO:0001915,negative regulation of T cell mediated cytotoxicity,M001,1,0
1,0,0,-2.8,0,0,GO:0072078,nephron tubule morphogenesis,M100,1,0
1,0,0,-2.2,0,0,GO:0043525,positive regulation of neuron apoptotic process,M100,1,0
1,0,0,-3.8,0,0,hsa04912,GnRH signaling pathway,M100,1,0
1,0,0,-2.8,0,0,GO:0043534,blood vessel endothelial cell migration,M100,1,0
1,0,0,-2.9,0,0,WP5272,LDL influence on CD14 and TLR4,M100,1,0
0,0,1,0,0,-2,GO:0002208,somatic diversification of immunoglobulins involved in immune response,M001,1,0
0,1,0,0,-2.8,0,GO:0061371,determination of heart left/right asymmetry,M010,1,0
1,0,0,-4,0,0,R-HSA-1989781,PPARA activates gene expression,M100,1,0
1,0,0,-4.9,0,0,GO:0032760,positive regulation of tumor necrosis factor production,M100,1,0
0,1,0,0,-2.4,0,GO:0007368,determination of left/right symmetry,M010,1,0
0,1,0,0,-2.1,0,R-HSA-500657,Presynaptic function of Kainate receptors,M010,1,0
1,0,0,-2,0,0,M226,PID VEGFR1 PATHWAY,M100,1,0
1,0,0,-2.2,0,0,GO:0045747,positive regulation of Notch signaling pathway,M100,1,0
1,0,0,-5.3,0,0,GO:0007612,learning,M100,1,0
1,0,0,-2.1,0,0,WP4298,Acute viral myocarditis,M100,1,0
1,0,0,-2.6,0,0,M44,PID HIF2PATHWAY,M100,1,0
0,1,0,0,-3.5,0,GO:0045787,positive regulation of cell cycle,M010,1,0
0,1,0,0,-4,0,GO:0002887,negative regulation of myeloid leukocyte mediated immunity,M010,1,0
0,0,1,0,0,-2.1,GO:0051961,negative regulation of nervous system development,M001,1,0
0,1,0,0,-3.7,0,GO:0050792,regulation of viral process,M010,1,0
1,0,0,-3,0,0,M141,PID PI3KCI PATHWAY,M100,1,0
0,1,0,0,-2.3,0,GO:0002283,neutrophil activation involved in immune response,M010,1,0
0,1,0,0,-2.6,0,GO:0009410,response to xenobiotic stimulus,M010,1,0
1,0,0,-3.3,0,0,M8,PID ENDOTHELIN PATHWAY,M100,1,0
1,0,0,-3.1,0,0,R-HSA-166166,MyD88-independent TLR4 cascade,M100,1,0
0,1,0,0,-2.3,0,WP3299,let 7 inhibition of ES cell reprogramming,M010,1,0
1,0,0,-3.3,0,0,GO:0036294,cellular response to decreased oxygen levels,M100,1,0
1,0,0,-3.1,0,0,hsa04724,Glutamatergic synapse,M100,1,0
1,0,0,-2.4,0,0,GO:0030032,lamellipodium assembly,M100,1,0
0,1,0,0,-2,0,GO:0030510,regulation of BMP signaling pathway,M010,1,0
1,0,0,-3.2,0,0,M166,PID ATF2 PATHWAY,M100,1,0
0,1,0,0,-2.1,0,R-HSA-4641265,Repression of WNT target genes,M010,1,0
0,1,0,0,-2.3,0,hsa05034,Alcoholism,M010,1,0
1,0,0,-2.4,0,0,WP5402,10q22q23 copy number variation,M100,1,0
0,1,0,0,-2.1,0,GO:0060415,muscle tissue morphogenesis,M010,1,0
1,0,0,-2.1,0,0,GO:0048665,neuron fate specification,M100,1,0
1,0,0,-2.5,0,0,WP138,Androgen receptor signaling pathway,M100,1,0
0,1,0,0,-2.8,0,GO:0060164,regulation of timing of neuron differentiation,M010,1,0
1,0,0,-2.3,0,0,WP2864,Apoptosis related network due to altered Notch3 in ovarian cancer,M100,1,0
1,0,0,-2.4,0,0,GO:0090207,regulation of triglyceride metabolic process,M100,1,0
1,0,0,-3,0,0,WP4754,IL 18 signaling pathway,M100,1,0
0,0,1,0,0,-2.2,GO:0060143,positive regulation of syncytium formation by plasma membrane fusion,M001,1,0
1,0,0,-2.3,0,0,WP2435,Quercetin and Nf kB AP 1 induced apoptosis,M100,1,0
0,0,1,0,0,-2.5,GO:0002312,B cell activation involved in immune response,M001,1,0
1,0,0,-3.5,0,0,GO:0046639,negative regulation of alpha-beta T cell differentiation,M100,1,0
1,0,0,-2.5,0,0,GO:0030518,intracellular steroid hormone receptor signaling pathway,M100,1,0
1,0,0,-2,0,0,GO:1905155,positive regulation of membrane invagination,M100,1,0
1,0,0,-3.5,0,0,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,M100,1,0
0,0,1,0,0,-2.2,GO:0097435,supramolecular fiber organization,M001,1,0
1,0,0,-3.1,0,0,R-HSA-1236394,Signaling by ERBB4,M100,1,0
1,0,0,-2.4,0,0,GO:0006140,regulation of nucleotide metabolic process,M100,1,0
1,0,0,-4,0,0,hsa04145,Phagosome,M100,1,0
1,0,0,-3.3,0,0,GO:0035282,segmentation,M100,1,0
0,0,1,0,0,-2,GO:2000311,regulation of AMPA receptor activity,M001,1,0
1,0,0,-4.5,0,0,GO:0042752,regulation of circadian rhythm,M100,1,0
1,0,0,-2.2,0,0,GO:0045332,phospholipid translocation,M100,1,0
1,0,0,-2.3,0,0,M106,PID HNF3B PATHWAY,M100,1,0
1,0,0,-5.3,0,0,hsa04936,Alcoholic liver disease,M100,1,0
0,0,1,0,0,-2.1,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),M001,1,0
0,0,1,0,0,-4,GO:1902170,cellular response to reactive nitrogen species,M001,1,0
1,0,0,-4.4,0,0,GO:0009267,cellular response to starvation,M100,1,0
1,0,0,-2.3,0,0,M127,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,M100,1,0
1,0,0,-2.1,0,0,M135,PID IL5 PATHWAY,M100,1,0
1,0,0,-2.9,0,0,GO:0043124,negative regulation of canonical NF-kappaB signal transduction,M100,1,0
1,0,0,-3.7,0,0,GO:2000181,negative regulation of blood vessel morphogenesis,M100,1,0
1,0,0,-3.7,0,0,hsa05162,Measles,M100,1,0
1,0,0,-2.7,0,0,GO:0014812,muscle cell migration,M100,1,0
1,0,0,-3.3,0,0,GO:0120163,negative regulation of cold-induced thermogenesis,M100,1,0
0,0,1,0,0,-3.2,R-HSA-6807070,PTEN Regulation,M001,1,0
0,1,0,0,-2.3,0,GO:0030335,positive regulation of cell migration,M010,1,0
0,1,0,0,-2.8,0,GO:0008544,epidermis development,M010,1,0
0,1,0,0,-2.3,0,GO:1902074,response to salt,M010,1,0
1,0,0,-2.1,0,0,GO:0010224,response to UV-B,M100,1,0
0,1,0,0,-2.3,0,GO:0045617,negative regulation of keratinocyte differentiation,M010,1,0
1,0,0,-2.1,0,0,GO:0006027,glycosaminoglycan catabolic process,M100,1,0
1,0,0,-2.4,0,0,GO:1990928,response to amino acid starvation,M100,1,0
0,1,0,0,-2.2,0,GO:0098655,monoatomic cation transmembrane transport,M010,1,0
1,0,0,-2.9,0,0,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,M100,1,0
0,1,0,0,-3.8,0,GO:0008015,blood circulation,M010,1,0
0,1,0,0,-2.1,0,GO:1900272,negative regulation of long-term synaptic potentiation,M010,1,0
0,1,0,0,-2.1,0,GO:0016925,protein sumoylation,M010,1,0
1,0,0,-2.4,0,0,GO:0061744,motor behavior,M100,1,0
0,1,0,0,-2.2,0,GO:0048538,thymus development,M010,1,0
0,1,0,0,-2.1,0,WP5074,Kallmann syndrome,M010,1,0
1,0,0,-4.5,0,0,GO:0010976,positive regulation of neuron projection development,M100,1,0
0,1,0,0,-2.2,0,GO:0086002,cardiac muscle cell action potential involved in contraction,M010,1,0
0,0,1,0,0,-2.3,GO:0060998,regulation of dendritic spine development,M001,1,0
1,0,0,-2.1,0,0,GO:0032753,positive regulation of interleukin-4 production,M100,1,0
0,1,0,0,-2.1,0,M165,PID SYNDECAN 4 PATHWAY,M010,1,0
0,0,1,0,0,-3.5,GO:1903845,negative regulation of cellular response to transforming growth factor beta stimulus,M001,1,0
1,0,0,-5.6,0,0,hsa04714,Thermogenesis,M100,1,0
0,1,0,0,-2.3,0,R-HSA-1980143,Signaling by NOTCH1,M010,1,0
1,0,0,-2.1,0,0,R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum  stress,M100,1,0
0,1,0,0,-2.4,0,GO:1905278,positive regulation of epithelial tube formation,M010,1,0
1,0,0,-2.8,0,0,GO:0002720,positive regulation of cytokine production involved in immune response,M100,1,0
1,0,0,-2.7,0,0,GO:2000352,negative regulation of endothelial cell apoptotic process,M100,1,0
1,0,0,-2.3,0,0,GO:0002396,MHC protein complex assembly,M100,1,0
0,0,1,0,0,-2.2,GO:0045616,regulation of keratinocyte differentiation,M001,1,0
0,0,1,0,0,-2.3,GO:0097529,myeloid leukocyte migration,M001,1,0
1,0,0,-2.4,0,0,GO:0030889,negative regulation of B cell proliferation,M100,1,0
0,1,0,0,-2.3,0,GO:0043523,regulation of neuron apoptotic process,M010,1,0
0,1,0,0,-2.2,0,GO:0060428,lung epithelium development,M010,1,0
1,0,0,-3.5,0,0,GO:0043536,positive regulation of blood vessel endothelial cell migration,M100,1,0
0,1,0,0,-2.1,0,GO:0032835,glomerulus development,M010,1,0
1,0,0,-2.1,0,0,WP4872,MAP3K1 role in promoting and blocking gonadal determination,M100,1,0
0,1,0,0,-2.5,0,GO:0043269,regulation of monoatomic ion transport,M010,1,0
1,0,0,-2.5,0,0,GO:0046636,negative regulation of alpha-beta T cell activation,M100,1,0
1,0,0,-2.2,0,0,GO:0090025,regulation of monocyte chemotaxis,M100,1,0
1,0,0,-4.2,0,0,M63,PID AVB3 OPN PATHWAY,M100,1,0
0,1,0,0,-4.3,0,GO:0048738,cardiac muscle tissue development,M010,1,0
0,1,0,0,-2.1,0,GO:0009101,glycoprotein biosynthetic process,M010,1,0
1,0,0,-2,0,0,WP384,Apoptosis modulation by HSP70,M100,1,0
1,0,0,-3.5,0,0,WP2332,Interleukin 11 signaling pathway,M100,1,0
0,1,0,0,-3.8,0,GO:0071635,negative regulation of transforming growth factor beta production,M010,1,0
1,0,0,-2.4,0,0,GO:0042753,positive regulation of circadian rhythm,M100,1,0
1,0,0,-2,0,0,GO:0002069,columnar/cuboidal epithelial cell maturation,M100,1,0
1,0,0,-2.1,0,0,GO:1900748,positive regulation of vascular endothelial growth factor signaling pathway,M100,1,0
1,0,0,-3.3,0,0,GO:0050869,negative regulation of B cell activation,M100,1,0
0,1,0,0,-3.7,0,GO:0040008,regulation of growth,M010,1,0
1,0,0,-2,0,0,GO:0032731,positive regulation of interleukin-1 beta production,M100,1,0
1,0,0,-2,0,0,WP1982,Sterol regulatory element binding proteins SREBP signaling,M100,1,0
1,0,0,-2,0,0,R-HSA-111997,CaM pathway,M100,1,0
0,1,0,0,-2.2,0,GO:0006024,glycosaminoglycan biosynthetic process,M010,1,0
0,1,0,0,-2.6,0,GO:0055017,cardiac muscle tissue growth,M010,1,0
1,0,0,-8.4,0,0,GO:0007611,learning or memory,M100,1,0
0,1,0,0,-2.1,0,GO:0048015,phosphatidylinositol-mediated signaling,M010,1,0
1,0,0,-2.1,0,0,GO:0045780,positive regulation of bone resorption,M100,1,0
0,1,0,0,-2.3,0,R-HSA-9020558,Interleukin-2 signaling,M010,1,0
0,0,1,0,0,-2.5,GO:1903902,positive regulation of viral life cycle,M001,1,0
0,1,0,0,-2.2,0,GO:0090090,negative regulation of canonical Wnt signaling pathway,M010,1,0
1,0,0,-5,0,0,GO:0034599,cellular response to oxidative stress,M100,1,0
0,1,0,0,-2.3,0,GO:0072106,regulation of ureteric bud formation,M010,1,0
1,0,0,-3.6,0,0,WP4658,Small cell lung cancer,M100,1,0
0,1,0,0,-2.5,0,GO:0048534,hematopoietic or lymphoid organ development,M010,1,0
1,0,0,-2.7,0,0,GO:0016444,somatic cell DNA recombination,M100,1,0
0,1,0,0,-2.6,0,GO:1901654,response to ketone,M010,1,0
1,0,0,-5.2,0,0,WP2018,RANKL RANK signaling pathway,M100,1,0
0,1,0,0,-2.1,0,GO:0003416,endochondral bone growth,M010,1,0
1,0,0,-2.9,0,0,GO:0060688,regulation of morphogenesis of a branching structure,M100,1,0
1,0,0,-5,0,0,GO:0031669,cellular response to nutrient levels,M100,1,0
1,0,0,-3.5,0,0,R-HSA-5602358,Diseases associated with the TLR signaling cascade,M100,1,0
0,1,0,0,-2.4,0,GO:0030178,negative regulation of Wnt signaling pathway,M010,1,0
0,1,0,0,-2.3,0,GO:0044703,multi-organism reproductive process,M010,1,0
1,0,0,-4.5,0,0,GO:0061180,mammary gland epithelium development,M100,1,0
1,0,0,-2.7,0,0,WP299,Nuclear receptors in lipid metabolism and toxicity,M100,1,0
0,1,0,0,-2.8,0,GO:0086065,cell communication involved in cardiac conduction,M010,1,0
0,0,1,0,0,-3.3,GO:0042088,T-helper 1 type immune response,M001,1,0
0,1,0,0,-2.1,0,GO:0072073,kidney epithelium development,M010,1,0
0,1,0,0,-4,0,GO:0003013,circulatory system process,M010,1,0
0,1,0,0,-5,0,GO:0002064,epithelial cell development,M010,1,0
1,0,0,-4.5,0,0,WP5053,Development of ureteric collection system,M100,1,0
0,0,1,0,0,-2.5,GO:0060142,regulation of syncytium formation by plasma membrane fusion,M001,1,0
0,1,0,0,-2.3,0,GO:0035470,positive regulation of vascular wound healing,M010,1,0
0,1,0,0,-2.1,0,GO:0001666,response to hypoxia,M010,1,0
1,0,0,-3.5,0,0,R-HSA-5260271,Diseases of Immune System,M100,1,0
1,0,0,-3.7,0,0,GO:0045646,regulation of erythrocyte differentiation,M100,1,0
0,0,1,0,0,-2.1,GO:0006935,chemotaxis,M001,1,0
